USRE41448E1 - Squitieri hemodialysis and vascular access systems - Google Patents

Squitieri hemodialysis and vascular access systems Download PDF

Info

Publication number
USRE41448E1
USRE41448E1 US10/219,998 US21999802A USRE41448E US RE41448 E1 USRE41448 E1 US RE41448E1 US 21999802 A US21999802 A US 21999802A US RE41448 E USRE41448 E US RE41448E
Authority
US
United States
Prior art keywords
hemodialysis
tube
access system
vascular access
vein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US10/219,998
Inventor
Rafael P. Squitieri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merit Medical Systems Inc
Original Assignee
Hemosphere Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/219,998 priority Critical patent/USRE41448E1/en
Application filed by Hemosphere Inc filed Critical Hemosphere Inc
Assigned to GRAFTCATH, INC. reassignment GRAFTCATH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SQUITIERI, RAFAEL \\
Priority to US11/417,658 priority patent/US20070123811A1/en
Assigned to HEMOSPHERE, INC. reassignment HEMOSPHERE, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: GRAFTCATH, INC.
Priority to US12/688,716 priority patent/USRE44639E1/en
Assigned to HEMOSPHERE MERGER CORP. reassignment HEMOSPHERE MERGER CORP. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HEMOSPHERE, INC.
Assigned to HEMOSPHERE, INC. reassignment HEMOSPHERE, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: HEMOSPHERE MERGER CORP.
Publication of USRE41448E1 publication Critical patent/USRE41448E1/en
Application granted granted Critical
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT reassignment GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT SECURITY AGREEMENT Assignors: HEMOSPHERE, INC.
Assigned to CRYOLIFE, INC. reassignment CRYOLIFE, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: HEMOSPHERE, INC.
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT reassignment GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CRYOLIFE, INC.
Assigned to HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT reassignment HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Assignors: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
Assigned to HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT reassignment HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CRYOLIFE, INC., AS GRANTOR, ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR, VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR
Assigned to MERIT MEDICAL SYSTEMS, INC. reassignment MERIT MEDICAL SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CRYOLIFE, INC.
Assigned to WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT reassignment WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MERIT MEDICAL SYSTEMS, INC.
Assigned to CRYOLIFE, INC., A FLORIDA CORPORATION reassignment CRYOLIFE, INC., A FLORIDA CORPORATION RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
Anticipated expiration legal-status Critical
Assigned to CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.), CRYOLIFE, INC., VALVE SPECIAL PURPOSE CO., LLC, CRYOLIFE ACQUISITION CORPORATION, ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.), HEMOSPHERE, INC. reassignment CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.) RELEASE OF SECURITY INTEREST IN PATENTS Assignors: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3653Interfaces between patient blood circulation and extra-corporal blood circuit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3653Interfaces between patient blood circulation and extra-corporal blood circuit
    • A61M1/3655Arterio-venous shunts or fistulae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0208Subcutaneous access sites for injecting or removing fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A61M2005/1581Right-angle needle-type devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0208Subcutaneous access sites for injecting or removing fluids
    • A61M2039/0211Subcutaneous access sites for injecting or removing fluids with multiple chambers in a single site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0247Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0258Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body for vascular access, e.g. blood stream access

Definitions

  • HD hemodialysis
  • vascular access for chemotherapy and plasmapheresis
  • Applicant's invention involves a new method and instrumentation for HD and vascular access designed to eliminate the problems of the prior methods and create a new, more durable, easier to use, vascular access system.
  • One prior art method involves a primary arteriovenous fistula.
  • a native artery is sewn to a native vein creating a high flow system of blood in a vein which over time can be accessed with two hemodialysis needles attached to a dialysis machine.
  • the problem with this method is that few patients are candidates secondary to anatomy and in others the veins or shunt fail to enlarge and mature properly even if the primary fistula remains patent.
  • These arteriovenous fistulas also become aneursymbol over time requiring revision.
  • Another method involves a subcutaneous prosthetic conduit (PTFE) in the shape of a tube which is sewn at either end to openings made in an artery and vein.
  • PTFE subcutaneous prosthetic conduit
  • This method causes recurrent stenosis at the venous outflow leading to thrombosis (i.e., graft closure) secondary to intimal hyperplasia at venous anastomosis.
  • thrombosis also occurs at needle puncture sites along the PTFE.
  • Another method involves a “tunneled” percutaneous dual lumen catheter which is inserted into a central vein. This causes recurrent thrombosis secondary to stasis of blood in the lumen (i.e., not a continuous flow system like an A-V fistula) and build up of fibrinous debris at the venous end. Further, the access end of the catheter protrudes through the skin making it cosmetically unappealing, cumbersome to live with, as well as more likely to become infected.
  • a further method involves the use of the Sorenson Catheter.
  • This is a percutaneous (not tunneled) dual lumen catheter, placed into the central venous system, which is used to provide temporary access for the purposes of hemodialysis. These catheters are prone to kinking, clotting, infection, and poor flow rates.
  • a still further method of vascular access involves the “Porta-a-cath”.
  • This system of venous access which utilizes a subcutaneous reservoir attached to a central venous catheter, is used for long term intervenous access for chemotherapy etc. (It is not intended for HD.)
  • the ports are prone to clotting and must be continually flushed since they are a stagnant system.
  • Applicant's invention involves a vascular access system, known as the Squitieri Hemodialysis and Vascular Access System, which creates a continuous blood flow and which is easily accessed and resistant to clotting.
  • vascular access system known as the Squitieri Hemodialysis and Vascular Access System
  • Squitieri Hemodialysis and Vascular Access System which creates a continuous blood flow and which is easily accessed and resistant to clotting.
  • a hemodialysis and vascular access system comprises a PTFE end which is sutured to an opening in an artery at one end and the other end is placed into a vein using any technique which avoids the need for an anastomosis between the silicone “venous” end of the catheter and the vein wall.
  • the system comprises any material, synthetic or natural (i.e. vein) which can be sutured to the artery (i.e. preferably PTFE) at one end while the other end is composed of a material which is suitable for placement into a vein in such a way that the openings in the “venous” end of the system are away from the site where the graft enters the vein.
  • the system may also be constructed of multiple layers of materials i.e. PTFE on the inside with silastic on the outside.
  • the “Needle Receiving Site” may also be covered with PTFE to encourage self sealing and tissue ingrowth.
  • a preferred embodiment comprises a combination of PTFE conduit sewn to an artery on one end of the system with the other end connected to a silastic-plastic catheter which can be percutaneously inserted into a vein via an introducer.
  • the venous end may also be placed via open cut down.
  • the seal around the system where it enters the vein may be “self sealing” when placed in percutaneous technique; it may be achieved with a purse string when done by open technique “cut down”; or, it may be sewn to the vein to create a seal with a “cuff” while the system continues downstream within the venous system to return the arterial blood away from the site of entry into the vein.
  • the entire system can be positioned subcutaneously at the completion of insertion.
  • This design is a significant improvement over existing methods because it avoids the most frequent complication of current HD access methods.
  • By utilizing an indwelling venous end one avoids creating a sewn anastomosis on a vein which is prone to stenosis secondary to neointimal hyperplasia.
  • By having continuous flow through the silastic end of the catheter thrombosis of these catheters can be avoided.
  • Dialysis is made more efficient by decreasing recirculation of blood which accompanies the use of side by side dual lumen catheters inserted into a central vein. This invention not only benefits the patient but it also speeds dialysis thus saving time and money.
  • the Squitieri Access System comprises a tube composed of PTFE and a silastic catheter. This tube is used to create an arteriovenous fistulu.
  • the PTFE end (arterial end) of the tube is sewn to an artery while the silastic catheter end is placed into the venous system by the Seldinger technique much like a standard central line.
  • the entire system is subcutaneous at the completion of insertion.
  • This system is a composite of the arterial end of a “gortex graft” joined to the venous end of a “permacath”. This system enjoys strengths of each type of access and at the same time avoids their weaknesses.
  • an object of this invention is to provide a new and improved vascular access system.
  • Another object of this invention is to provide a new and improved hemodialysis and vascular access system including an easily replaceable needle receiving site which has superior longevity and performance, is more easily implanted, more easily replaced, and is “user friendly” i.e. easily and safely accessed by a nurse or patient which is ideal for home hemodialysis.
  • a more specific object of this invention is to provide a new and improved Squitieri hemodialysis and vascular access system including a subcutaneous composite PTFE/Silastic arteriovenous fistula.
  • a further object of this invention is to provide a new and improved hemodialysis and vascular access system including a fistula utilizing an indwelling silastic end which is inserted percutaneously into the venous system and a PTFE arterial end which is anastomosed to an artery and including a unique needle receiving sites which are positioned anywhere between the ends and which have superior longevity and performance.
  • a further object of this invention is to provide a system constructed to preserve laminar flow within the system and at the venous outflow end to reduce turbulence and shear force in the vascular system to the degree possible.
  • a still further object of this invention is to provide a system wherein the arterial end (PTFE) may also be placed by percutaneous technique including one where blood entry holes are distant from the site where blood enters the veins.
  • PTFE arterial end
  • FIG. 1 is a perspective view of the vascular access system comprising the invention
  • FIG. 2 is a cross-sectional view of the needle access site taken along the line 2 — 2 of FIG. 1 ;
  • FIG. 3 is a cross-sectional view similar to FIG. 2 with a needle inserted into the access site;
  • FIG. 4 is a cross-sectional view of the coupling between the PTFE and the silicone venous end of the catheter;
  • FIG. 5 is a perspective view of an alternate embodiment of the invention with one port having a tube sewn to a vein;
  • FIG. 7 illustrates a ringed tube sewn to an artery and connected to a first access site which is joined to a second site by silastic tubing and includes an outflow through silastic tubing which is floated into the venous system;
  • FIG. 8 is similar to FIG. 7 but shows PTFE sewn to an artery and silastic tubing floated into a different portion of the venous system;
  • FIG. 9 depicts ringed PTFE tubing sewn to the subclavian artery and a dual access site coupled to the venous system at its other end;
  • FIG. 10 shows a multi-layered variation at the venous end of the system
  • FIG. 11 discloses a quick coupler design utilized in conjunction with the system
  • FIG. 12 is a unique port design utilized in conjunction with the system
  • FIG. 13 shows holes where ports can be fixed in place while FIG. 13 a and FIG. 13b show cross-sectional views which depict the internal construction of the invention with FIG. 13b illustrating multi-layered tubing; and,
  • FIG. 14 shows a variation of the system entry through vein wall (i.e. not percutaneous or purse string) wherein a cuff, sewn to vein as indwelling portion, is floated down stream.
  • the Squitieri hemodialysis and vascular system as shown in FIG. 1 , comprises a PTFE/dacron (or other synthetic or natural material) tube 10 of several centimeters in length which is attached at one end by means of a coupling 11 to a needle access site 20 .
  • Adjustable band 18 regulates the blood flow through the access site 20 .
  • the PTFE tube 10 is approximately 7 mm in diameter and transitions downward to an open end portion 19 approximately 4 mm in diameter.
  • the access site 20 includes an in line aperture 16 , see FIG. 2 , having a silicone tube 41 connected thereto at one end leading to a long flexible plastic/silastic/silicone tube 12 with transverse holes 13 along its free end.
  • the number of holes 13 may vary within predetermined limits to achieve optimum results.
  • the end 36 may be beveled for ease of insertion.
  • This tubular arrangement functions as a subcutaneous connection between the arterial and venous systems. It may also be modified to allow part of the system to exit through the skin 14 to provide access to the blood circulation without placing needles 15 through the skin 14 into the fistula (usually at the PTFE end).
  • the needle access areas 20 which are designed to receive needles 15 etc. to allow access to the system are in line conduits with self-sealing material 17 such as silicone located beneath the skin surface.
  • the silicone member 25 comprises an oval configuration exposed within the frame 26 for ease of puncture.
  • the system may be accessed immediately after insertion without having to wait for the graft to incorporate into the tissues as is the case with the current methods of subcutaneous fistulas.
  • These access areas 20 will protect the graft since they are uniformly and easily utilized requiring little training or experience.
  • the “needle receiving” sites 20 are designed in such a way to preserve laminar flow as far as possible (i.e. not a reservoir arrangement). Needle receiver sites 20 may be connected to a system via “quick couple” 45 for easy exchangability, see FIG. 11 .
  • FIGS. 2 and 3 disclose a needle access site 20 wherein a silicone member 25 is mounted within a plastic or metal frame 26 .
  • a protruding portion 27 of member 25 extends upwardly through the aperture 31 while a flange portion 28 extends outwardly on both sides of the portion 27 to be gripped by teeth 29 on the internal surface of frame 26 and member 32 .
  • the member 26 includes a passage 16 for blood flow. The blood flow is accessed by inserting needles 15 through the silicone 25 which is preferably oval in shape. The teeth 29 seal the arterial pressure.
  • the internal chamber 16 of the needle receiving site 20 is tubular in shape.
  • the free end 19 of the PTFE tube 10 is sewn to an opening in an artery 30 , see FIG. 7 , while the plastic end 24 having been inserted percutaneously lies in the venous system in such a way that the openings 13 in the silastic tube 12 are downstream from the site where the flexible plastic tube 24 enters the vein 40 .
  • the venous end may be inserted via “cutdown”.
  • the purpose of the system is to allow communication between an artery 30 and a vein 40 in such a way that the system may be accessed by either puncturing the PTFE segment or by entering the specialized “needle receiving” site 20 . This allows blood to flow from the system to a hemodialysis machine (not shown) and then return into the venous outflow portion at a more distal (venous end) location allowing the blood 35 to return from the HD machine (not shown) back into the patient.
  • FIG. 4 discloses, as an alternative, a “glued” connection between PTFE tubing 60 and silicone tubing 61 wherein the PTFE 61 is inserted into an enlarged portion of silicone 61 wherein the longitudinally extending portion includes a raised section 63 which locks a raised section 64 of PTFE 61 within the silicone 60 .
  • the materials used may vary as specified herein.
  • the system may be constructed of one or more specific materials.
  • the arteries and veins used may also vary.
  • Material may also be covered with thrombus resistant coatings (heparin, etc.) or biologic tissue.
  • the system may in specific cases be “ringed” for support.
  • the system comprises an arterial reservoir structure or port 50 with a needle accessible top portion 51 preferably constructed of silicone.
  • the reservoir 50 is connected to an outlet tube 53 of PTFE (gortex-ringed), which is sewn to an artery 30 at its other end.
  • PTFE glycol-ringed
  • the venous outlet tube 52 is constructed in a similar way but it is either sewn to a vein 40 via gortex ringed portion 52 52 a or is placed percutaneously into the central circulation via an indwelling venous (silicon) catheter 42 as shown in FIG. 6 . There is no continuous flow through this version of the system since the ports are not connected.
  • FIG. 6 shows two separate ports 51 a and 51 b with one the tube 53 sewn to an artery 30 and the other tube 42 floated down a vein 40 .
  • FIG. 7 illustrates in an anatomical drawing, a ringed gortex tubing 53 sewn to an artery 30 at 62 and coupled at its other end 63 to the needle access site 20 .
  • the site 20 see FIGS. 1-3 , is joined by silastic tubing 64 to a second access site 20 a which has an outlet silastic tube 65 .
  • the outlet tube 65 includes a plurality of perforations 66 at its outlet end which is positioned in the venous system 67 through vein 40 . Either site 20 or 20 a can be used for needle access.
  • FIG. 8 depicts an embodiment similar to that of FIG. 7 except that the coupling between the artery 30 and the first needle access site 20 is PTFE tube 69 .
  • the entry to the venous system 67 is via vein 40 which has silastic tubing 65 floated therein.
  • 69 a depicts PTFE joining parts 20 and 20 a.
  • FIG. 9 illustrates a dual needle access site 80 which is coupled via ringed PTFE 53 to the subclavian artery 30 and floated into the venous system 67 via silastic tubing 65 .
  • the dual site 80 provides additional access through 25 a, 25 b in approximately the same area with tubing (not shown) extending through the dual site 80 .
  • FIG. 10 depicts a variation of the invention at the venous end wherein the outlet of the port 20 comprises PTFE tubing 91 located within a silastic catheter 92 .
  • the design is appropriate if thrombosis is a problem in the outlet silastic portion of the shunt.
  • FIG. 11 discloses a quick coupler 45 joining the PTFE tubingoutlet tube 53 to the port 46 in the needle access site 20 .
  • a plastic or metal member 47 includes a portion 48 which engages the cylindrical tubing 10 , an intermediate portion 49 extending perpendicularly outward and an end portion 43 tapered outwardly at an angle and including an inward projection 44 .
  • the projecting portion 44 of the member 47 engages a slot 54 in the port 46 firmly fixing the PTFE 10 therebetween.
  • aPortion 48 is made of flexible material to allow a gentle curve in tubing as it exits/enters the port.
  • FIG. 12 is an exploded view of a new port embodiment wherein the port 71 comprises a frame 72 having an inlet 73 and an outlet 74 .
  • the plastic or metal frame 75 includes a recessed reservoir 76 and end walls 78 a and 78 b.
  • An upper member 85 having a recess 86 and downwardly projecting sides 87 a and 87 b fits within walls 77 a and 77 b.
  • the member 45 rapidly couples the PTFE tubing 10 to site 71 with tubing 88 which fits over the inlet coupling 73 and the outlet coupling 74 with recessed portions 75 a and 75 b which engage tubing 88 a and 88 b and have couplers 89 a and 89 b which slide over the tubing 88 a, 88 b to engage the couplings 73 and 74 .
  • FIG. 13 shows a typical dual port system showing holes 55 where ports 20 can be fixed in place.
  • FIG. 14 discloses a cuff 56 which is made of PTFE and sewn to a vein. No physiological/functional venues anastomosis is created as blood is returned at the end of the system distant from the cuff.
  • the silastic end 12 may still be lined with PTFE.
  • the upper member 86 includes an oval silicone access site 90 with an outer housing 91 which includes an aperture 92 surrounds the silicone oval 90 .
  • This embodiment provides a quick assembly for a needle access site 71 .
  • the Squitieri Hemodialysis/Vascular Access System avoids creation of a venous anastomosis, a revolutionary advancement, i.e. there is no site for neointimal hyperplasia at a venous anastomosis which accounts for the vast majority of PTFE arteriovenous graft failures (60-80%). This is accomplished by returning the blood into a larger vein via an indwelling venous catheter 42 . The site of blood return to the venous system is not fixed to the vein wall where neointimal hyperplasia occurs with the standard PTFE bridge graft. This feature represents a tremendous advantage over the present grafts.
  • the system is not stagnant and prone to thrombosis, i.e. constant flow through the new system avoids the problem of clotting inherent in indwelling dual lumen venous catheters which remain stagnant when not in use. It also avoids need to flush catheters with heplock thereby reducing nursing costs to maintain the catheter.
  • the Squitieri system avoids externalization of components which are prone to infection. Since dual lumen catheters exit the skin 14 , they frequently lead to sepsis requiring catheter removal despite subcutaneous tunneling. This new access is entirely subcutaneous.
  • the system proposed herein avoids problems with the aspiration of blood from the venous system and “positional” placement through continuous flow.
  • a frequent problem with dual lumen catheters is their inability to draw blood from the venous system due to clot and fibrinous debris ball-valving at the tip of a catheter.
  • This new system receives blood directly from arterial inflow which ensures high flow rates needed for shorter, more efficient dialysis runs. It also avoids the frequent problem of the catheter tip “sucking” on the vein wall inhibiting flow to the dialysis machine and rendering the access ineffective.
  • the system avoids recirculation seen with dual lumen catheters resulting in more efficient and more cost effective dialysis.
  • the system avoids the need for temporary access with incorporation of “Needle Access Sites” 20 .
  • A-V fistulas and gortex grafts must “mature” for several weeks before use. This creates a huge strain on the patient as well as the doctor to achieve temporary access while waiting to use the permanent access.
  • Temporary access is very prone to infection, malfunction and vein destruction.
  • Needle Access Sites 20 The system avoids PTFE needle site damage with the incorporation of “Needle Access Sites” 20 . Needle access directly into PTFE is presently uncontrolled and user dependent. Often, PTFE is lacerated by access needles. While this system may be accessed via the PTFE segment, the needle receiving sites are the preferred method. This leads to excessive bleeding which requires excessive pressure to halt the bleeding causing thrombosis of the graft. “Needle Access Sites” 20 on the Squitieri access system allow safe, quick, and easy entry into the system and avoid the complications inherent in placing needles directly into PTFE. It also avoids perigraft bleeding which will compress and thrombose the graft. By elminating the long time needed to compress bleeding at the needle site, the system shortens dialysis runs.
  • the Squitieri system permits an easier, faster insertion technique. Only one anastomosis at the arterial end and a percutaneous placement of the venous end is required. A modification allows the system to be sutured to the vein wall while the system tubing is floated down stream from this site where the system enters the vein 40 . This saves operating room time at thousands of dollars per hour. The technique is easier with faster replacement. It avoids difficult and time consuming revision of venous anastomosis required to repair venous outflow occluded by neointimal hyperplasia. If the system malfunctions, the silastic catheter end 65 slips out easily and the arterial PTFE end 53 is thrombectomized. New access sewn to the thrombectomized PTFE at the arterial end and the silastic venous end is replaced percutaneously via Seldinger technique or “open technique”.

Abstract

A hemodialysis and vascular access system comprises a subcutaneous composite PTFE silastic arteriovenous fistula having an indwelling silastic venous end which is inserted percutaneously into a vein and a PTFE arterial end which is anastomosed to an artery. Access to a blood stream within the system is gained by direct puncture of needle(s) into a needle receiving site having a tubular passage within a metal or plastic frame and a silicone upper surface through which needle(s) are inserted. In an alternate embodiment of the invention, percutaneous access to a blood stream may be gained by placing needles directly into the system (i.e. into the PTFE arterial end). The invention also proposes an additional embodiment having an arterialized indwelling venous catheter where blood flows from an artery through a tube and a port into an arterial reservoir and is returned to a vein via a port and a venous outlet tube distinct and distant from the area where the blood from the artery enters the arterial reservoir. The site where blood is returned to the vein is not directly fixed to the venous wall but is free floating within the vein. This system provides a hemodialysis and venous access graft which has superior longevity and performance, is easier to implant and is much more user friendly.

Description

This is a reissue application of U.S. Pat. No. 6,102,884, which issued on Aug. 15, 2000, and which claims benefit under 35 U.S.C. Section 119(e) to U.S. Provisional Patent Application Ser. No. 60/037,094, filed Feb. 3, 1997.
Notice: More than one reissue application has been filed for the reissue of U.S. Pat. No. 6,102,884. The reissue applications are U.S. application Ser. No. 10/219,998 (the present application) and U.S. application Ser. No. 11/417,658, which is a continuation reissue of U.S. Pat. No. 6,102,884.
BACKGROUND OF THE INVENTION
Currently, HD (hemodialysis) and vascular access for chemotherapy and plasmapheresis is achieved in one of several ways. Applicant's invention involves a new method and instrumentation for HD and vascular access designed to eliminate the problems of the prior methods and create a new, more durable, easier to use, vascular access system.
One prior art method involves a primary arteriovenous fistula. In this method, a native artery is sewn to a native vein creating a high flow system of blood in a vein which over time can be accessed with two hemodialysis needles attached to a dialysis machine. The problem with this method is that few patients are candidates secondary to anatomy and in others the veins or shunt fail to enlarge and mature properly even if the primary fistula remains patent. These arteriovenous fistulas also become aneursymbol over time requiring revision.
Another method involves a subcutaneous prosthetic conduit (PTFE) in the shape of a tube which is sewn at either end to openings made in an artery and vein. This method causes recurrent stenosis at the venous outflow leading to thrombosis (i.e., graft closure) secondary to intimal hyperplasia at venous anastomosis. Thrombosis also occurs at needle puncture sites along the PTFE.
Another method involves a “tunneled” percutaneous dual lumen catheter which is inserted into a central vein. This causes recurrent thrombosis secondary to stasis of blood in the lumen (i.e., not a continuous flow system like an A-V fistula) and build up of fibrinous debris at the venous end. Further, the access end of the catheter protrudes through the skin making it cosmetically unappealing, cumbersome to live with, as well as more likely to become infected.
A further method involves the use of the Sorenson Catheter. This is a percutaneous (not tunneled) dual lumen catheter, placed into the central venous system, which is used to provide temporary access for the purposes of hemodialysis. These catheters are prone to kinking, clotting, infection, and poor flow rates.
A still further method of vascular access involves the “Porta-a-cath”. This system of venous access, which utilizes a subcutaneous reservoir attached to a central venous catheter, is used for long term intervenous access for chemotherapy etc. (It is not intended for HD.) The ports are prone to clotting and must be continually flushed since they are a stagnant system.
Applicant's invention involves a vascular access system, known as the Squitieri Hemodialysis and Vascular Access System, which creates a continuous blood flow and which is easily accessed and resistant to clotting. These advantages provide ideal access for long term HD, chemo or blood draws. An example, would be patients who are on coumadin which require weekly blood draws. This new system becomes less painful over time as the skin over the “needle access” site become less sensitive. The veins are spared repeated blood draws which results in vein thrombosis to such a degree that some patients “have no veins left” making routine blood draws impossible.
Among the more relevant prior art patents are U.S. Pat. Nos. 4,898,669; 4,822,341; 5,041,098; and, 4,790,826. None of the foregoing patents disclose a system having the features of this inventions
SUMMARY OF THE INVENTION
A hemodialysis and vascular access system comprises a PTFE end which is sutured to an opening in an artery at one end and the other end is placed into a vein using any technique which avoids the need for an anastomosis between the silicone “venous” end of the catheter and the vein wall. The system comprises any material, synthetic or natural (i.e. vein) which can be sutured to the artery (i.e. preferably PTFE) at one end while the other end is composed of a material which is suitable for placement into a vein in such a way that the openings in the “venous” end of the system are away from the site where the graft enters the vein. The system may also be constructed of multiple layers of materials i.e. PTFE on the inside with silastic on the outside. The “Needle Receiving Site” may also be covered with PTFE to encourage self sealing and tissue ingrowth.
A preferred embodiment comprises a combination of PTFE conduit sewn to an artery on one end of the system with the other end connected to a silastic-plastic catheter which can be percutaneously inserted into a vein via an introducer. The venous end may also be placed via open cut down. The seal around the system where it enters the vein may be “self sealing” when placed in percutaneous technique; it may be achieved with a purse string when done by open technique “cut down”; or, it may be sewn to the vein to create a seal with a “cuff” while the system continues downstream within the venous system to return the arterial blood away from the site of entry into the vein. The entire system can be positioned subcutaneously at the completion of insertion. This design is a significant improvement over existing methods because it avoids the most frequent complication of current HD access methods. By utilizing an indwelling venous end, one avoids creating a sewn anastomosis on a vein which is prone to stenosis secondary to neointimal hyperplasia. By having continuous flow through the silastic end of the catheter, thrombosis of these catheters can be avoided. Dialysis is made more efficient by decreasing recirculation of blood which accompanies the use of side by side dual lumen catheters inserted into a central vein. This invention not only benefits the patient but it also speeds dialysis thus saving time and money.
To summarize, the Squitieri Access System comprises a tube composed of PTFE and a silastic catheter. This tube is used to create an arteriovenous fistulu. The PTFE end (arterial end) of the tube is sewn to an artery while the silastic catheter end is placed into the venous system by the Seldinger technique much like a standard central line. The entire system is subcutaneous at the completion of insertion. This system is a composite of the arterial end of a “gortex graft” joined to the venous end of a “permacath”. This system enjoys strengths of each type of access and at the same time avoids their weaknesses.
Accordingly, an object of this invention is to provide a new and improved vascular access system.
Another object of this invention is to provide a new and improved hemodialysis and vascular access system including an easily replaceable needle receiving site which has superior longevity and performance, is more easily implanted, more easily replaced, and is “user friendly” i.e. easily and safely accessed by a nurse or patient which is ideal for home hemodialysis.
A more specific object of this invention is to provide a new and improved Squitieri hemodialysis and vascular access system including a subcutaneous composite PTFE/Silastic arteriovenous fistula.
A further object of this invention is to provide a new and improved hemodialysis and vascular access system including a fistula utilizing an indwelling silastic end which is inserted percutaneously into the venous system and a PTFE arterial end which is anastomosed to an artery and including a unique needle receiving sites which are positioned anywhere between the ends and which have superior longevity and performance.
A further object of this invention is to provide a system constructed to preserve laminar flow within the system and at the venous outflow end to reduce turbulence and shear force in the vascular system to the degree possible.
A still further object of this invention is to provide a system wherein the arterial end (PTFE) may also be placed by percutaneous technique including one where blood entry holes are distant from the site where blood enters the veins.
BRIEF DESCRIPTION OF THE DRAWINGS
The above and other objects of this invention may be more clearly seen when viewed in conjunction with the accompanying drawings wherein:
FIG. 1 is a perspective view of the vascular access system comprising the invention;
FIG. 2 is a cross-sectional view of the needle access site taken along the line 22 of FIG. 1;
FIG. 3 is a cross-sectional view similar to FIG. 2 with a needle inserted into the access site;
FIG. 4 is a cross-sectional view of the coupling between the PTFE and the silicone venous end of the catheter;
FIG. 5 is a perspective view of an alternate embodiment of the invention with one port having a tube sewn to a vein;
FIG. 6 is a perspective view of the embodiment in FIG. 5 with a silastic tube floated down a vein;
FIG. 7 illustrates a ringed tube sewn to an artery and connected to a first access site which is joined to a second site by silastic tubing and includes an outflow through silastic tubing which is floated into the venous system;
FIG. 8 is similar to FIG. 7 but shows PTFE sewn to an artery and silastic tubing floated into a different portion of the venous system;
FIG. 9 depicts ringed PTFE tubing sewn to the subclavian artery and a dual access site coupled to the venous system at its other end;
FIG. 10 shows a multi-layered variation at the venous end of the system;
FIG. 11 discloses a quick coupler design utilized in conjunction with the system;
FIG. 12 is a unique port design utilized in conjunction with the system;
FIG. 13 shows holes where ports can be fixed in place while FIG. 13a and FIG. 13b show cross-sectional views which depict the internal construction of the invention with FIG. 13b illustrating multi-layered tubing; and,
FIG. 14 shows a variation of the system entry through vein wall (i.e. not percutaneous or purse string) wherein a cuff, sewn to vein as indwelling portion, is floated down stream.
DETAILED DESCRIPTION OF THE INVENTION
Referring to the drawings the Squitieri hemodialysis and vascular system, as shown in FIG. 1, comprises a PTFE/dacron (or other synthetic or natural material) tube 10 of several centimeters in length which is attached at one end by means of a coupling 11 to a needle access site 20. Adjustable band 18 regulates the blood flow through the access site 20. The PTFE tube 10 is approximately 7 mm in diameter and transitions downward to an open end portion 19 approximately 4 mm in diameter.
The access site 20 includes an in line aperture 16, see FIG. 2, having a silicone tube 41 connected thereto at one end leading to a long flexible plastic/silastic/silicone tube 12 with transverse holes 13 along its free end. The number of holes 13 may vary within predetermined limits to achieve optimum results. The end 36 may be beveled for ease of insertion. This tubular arrangement functions as a subcutaneous connection between the arterial and venous systems. It may also be modified to allow part of the system to exit through the skin 14 to provide access to the blood circulation without placing needles 15 through the skin 14 into the fistula (usually at the PTFE end).
Along the length of the catheter specially constructed access segments 20 are located to receive specially designed needles 15 into the system to gain access to the blood stream which flows through aperture 16. This method avoids perigraft bleeding which leads to thrombosis either by compression of the graft by hematoma or by manual pressure applied to the graft in an attempt to control the bleeding.
The needle access areas 20 which are designed to receive needles 15 etc. to allow access to the system are in line conduits with self-sealing material 17 such as silicone located beneath the skin surface. The silicone member 25 comprises an oval configuration exposed within the frame 26 for ease of puncture. The system may be accessed immediately after insertion without having to wait for the graft to incorporate into the tissues as is the case with the current methods of subcutaneous fistulas. These access areas 20 will protect the graft since they are uniformly and easily utilized requiring little training or experience. The “needle receiving” sites 20 are designed in such a way to preserve laminar flow as far as possible (i.e. not a reservoir arrangement). Needle receiver sites 20 may be connected to a system via “quick couple” 45 for easy exchangability, see FIG. 11.
FIGS. 2 and 3 disclose a needle access site 20 wherein a silicone member 25 is mounted within a plastic or metal frame 26. A protruding portion 27 of member 25 extends upwardly through the aperture 31 while a flange portion 28 extends outwardly on both sides of the portion 27 to be gripped by teeth 29 on the internal surface of frame 26 and member 32. The member 26 includes a passage 16 for blood flow. The blood flow is accessed by inserting needles 15 through the silicone 25 which is preferably oval in shape. The teeth 29 seal the arterial pressure. The internal chamber 16 of the needle receiving site 20 is tubular in shape.
The free end 19 of the PTFE tube 10 is sewn to an opening in an artery 30, see FIG. 7, while the plastic end 24 having been inserted percutaneously lies in the venous system in such a way that the openings 13 in the silastic tube 12 are downstream from the site where the flexible plastic tube 24 enters the vein 40. The venous end may be inserted via “cutdown”. The purpose of the system is to allow communication between an artery 30 and a vein 40 in such a way that the system may be accessed by either puncturing the PTFE segment or by entering the specialized “needle receiving” site 20. This allows blood to flow from the system to a hemodialysis machine (not shown) and then return into the venous outflow portion at a more distal (venous end) location allowing the blood 35 to return from the HD machine (not shown) back into the patient.
FIG. 4 discloses, as an alternative, a “glued” connection between PTFE tubing 60 and silicone tubing 61 wherein the PTFE 61 is inserted into an enlarged portion of silicone 61 wherein the longitudinally extending portion includes a raised section 63 which locks a raised section 64 of PTFE 61 within the silicone 60.
In this invention, the materials used may vary as specified herein. The system may be constructed of one or more specific materials. The arteries and veins used may also vary. Material may also be covered with thrombus resistant coatings (heparin, etc.) or biologic tissue. The system may in specific cases be “ringed” for support.
The same concept of using an arterialized venous access catheter may be applied to the use of long term indwelling catheters used to give chemotherapy etc., making the current ports obsolete as these new access systems will have a decreased thrombosis and they will no longer need to be flushed as continuous blood flow through the system makes thrombus formation unlikely. This will definitely cut down on costs since it will decrease nursing requirements in out patient settings, etc.
In alternate embodiments shown in FIGS. 5 and 6, the system comprises an arterial reservoir structure or port 50 with a needle accessible top portion 51 preferably constructed of silicone. The reservoir 50 is connected to an outlet tube 53 of PTFE (gortex-ringed), which is sewn to an artery 30 at its other end. The venous outlet tube 52 is constructed in a similar way but it is either sewn to a vein 40 via gortex ringed portion 52 52a or is placed percutaneously into the central circulation via an indwelling venous (silicon) catheter 42 as shown in FIG. 6. There is no continuous flow through this version of the system since the ports are not connected. Flow is established when the system is attached to an HD machine with a needle 15 in the arterial port 51a to deliver blood to the HD machine and a second needle 15 is placed in the venous port 51b to the vein 40 to deliver blood to the patient. The ports 51a, 51b will remain flushed with heparin when not in use to avoid clotting when accessed through the skin 14 with needles 15. The ports 51a, 51b will also provide high flow access to both the arterial and venous systems. FIG. 6 shows two separate ports 51a and 51b with one the tube 53 sewn to an artery 30 and the other tube 42 floated down a vein 40.
FIG. 7 illustrates in an anatomical drawing, a ringed gortex tubing 53 sewn to an artery 30 at 62 and coupled at its other end 63 to the needle access site 20. The site 20, see FIGS. 1-3, is joined by silastic tubing 64 to a second access site 20a which has an outlet silastic tube 65. The outlet tube 65 includes a plurality of perforations 66 at its outlet end which is positioned in the venous system 67 through vein 40. Either site 20 or 20a can be used for needle access.
FIG. 8 depicts an embodiment similar to that of FIG. 7 except that the coupling between the artery 30 and the first needle access site 20 is PTFE tube 69. The entry to the venous system 67 is via vein 40 which has silastic tubing 65 floated therein. 69a depicts PTFE joining parts 20 and 20a.
FIG. 9 illustrates a dual needle access site 80 which is coupled via ringed PTFE 53 to the subclavian artery 30 and floated into the venous system 67 via silastic tubing 65. The dual site 80 provides additional access through 25a, 25b in approximately the same area with tubing (not shown) extending through the dual site 80.
FIG. 10 depicts a variation of the invention at the venous end wherein the outlet of the port 20 comprises PTFE tubing 91 located within a silastic catheter 92. The design is appropriate if thrombosis is a problem in the outlet silastic portion of the shunt.
FIG. 11 discloses a quick coupler 45 joining the PTFE tubingoutlet tube 53 to the port 46 in the needle access site 20. A plastic or metal member 47 includes a portion 48 which engages the cylindrical tubing 10, an intermediate portion 49 extending perpendicularly outward and an end portion 43 tapered outwardly at an angle and including an inward projection 44. The projecting portion 44 of the member 47 engages a slot 54 in the port 46 firmly fixing the PTFE 10 therebetween. 45aPortion 48is made of flexible material to allow a gentle curve in tubing as it exits/enters the port.
FIG. 12 is an exploded view of a new port embodiment wherein the port 71 comprises a frame 72 having an inlet 73 and an outlet 74. The plastic or metal frame 75 includes a recessed reservoir 76 and end walls 78a and 78b. An upper member 85 having a recess 86 and downwardly projecting sides 87a and 87b fits within walls 77a and 77b. The member 45 rapidly couples the PTFE tubing 10 to site 71 with tubing 88 which fits over the inlet coupling 73 and the outlet coupling 74 with recessed portions 75a and 75b which engage tubing 88a and 88b and have couplers 89a and 89b which slide over the tubing 88a, 88b to engage the couplings 73 and 74.
FIG. 13 shows a typical dual port system showing holes 55 where ports 20 can be fixed in place.
FIG. 14 discloses a cuff 56 which is made of PTFE and sewn to a vein. No physiological/functional venues anastomosis is created as blood is returned at the end of the system distant from the cuff. The silastic end 12 may still be lined with PTFE.
The upper member 86 includes an oval silicone access site 90 with an outer housing 91 which includes an aperture 92 surrounds the silicone oval 90. This embodiment provides a quick assembly for a needle access site 71.
The Squitieri Hemodialysis/Vascular Access System avoids creation of a venous anastomosis, a revolutionary advancement, i.e. there is no site for neointimal hyperplasia at a venous anastomosis which accounts for the vast majority of PTFE arteriovenous graft failures (60-80%). This is accomplished by returning the blood into a larger vein via an indwelling venous catheter 42. The site of blood return to the venous system is not fixed to the vein wall where neointimal hyperplasia occurs with the standard PTFE bridge graft. This feature represents a tremendous advantage over the present grafts.
As a further advantage, the system is not stagnant and prone to thrombosis, i.e. constant flow through the new system avoids the problem of clotting inherent in indwelling dual lumen venous catheters which remain stagnant when not in use. It also avoids need to flush catheters with heplock thereby reducing nursing costs to maintain the catheter.
The Squitieri system avoids externalization of components which are prone to infection. Since dual lumen catheters exit the skin 14, they frequently lead to sepsis requiring catheter removal despite subcutaneous tunneling. This new access is entirely subcutaneous.
Very importantly the system proposed herein, avoids problems with the aspiration of blood from the venous system and “positional” placement through continuous flow. A frequent problem with dual lumen catheters is their inability to draw blood from the venous system due to clot and fibrinous debris ball-valving at the tip of a catheter. This new system receives blood directly from arterial inflow which ensures high flow rates needed for shorter, more efficient dialysis runs. It also avoids the frequent problem of the catheter tip “sucking” on the vein wall inhibiting flow to the dialysis machine and rendering the access ineffective.
The system avoids recirculation seen with dual lumen catheters resulting in more efficient and more cost effective dialysis.
The system avoids the need for temporary access with incorporation of “Needle Access Sites” 20. A-V fistulas and gortex grafts must “mature” for several weeks before use. This creates a huge strain on the patient as well as the doctor to achieve temporary access while waiting to use the permanent access. Temporary access is very prone to infection, malfunction and vein destruction. By placing sites 20 designed to receive needles 15 along the new access, the system may be used the day it is inserted.
The system avoids PTFE needle site damage with the incorporation of “Needle Access Sites” 20. Needle access directly into PTFE is presently uncontrolled and user dependent. Often, PTFE is lacerated by access needles. While this system may be accessed via the PTFE segment, the needle receiving sites are the preferred method. This leads to excessive bleeding which requires excessive pressure to halt the bleeding causing thrombosis of the graft. “Needle Access Sites” 20 on the Squitieri access system allow safe, quick, and easy entry into the system and avoid the complications inherent in placing needles directly into PTFE. It also avoids perigraft bleeding which will compress and thrombose the graft. By elminating the long time needed to compress bleeding at the needle site, the system shortens dialysis runs.
The Squitieri system permits an easier, faster insertion technique. Only one anastomosis at the arterial end and a percutaneous placement of the venous end is required. A modification allows the system to be sutured to the vein wall while the system tubing is floated down stream from this site where the system enters the vein 40. This saves operating room time at thousands of dollars per hour. The technique is easier with faster replacement. It avoids difficult and time consuming revision of venous anastomosis required to repair venous outflow occluded by neointimal hyperplasia. If the system malfunctions, the silastic catheter end 65 slips out easily and the arterial PTFE end 53 is thrombectomized. New access sewn to the thrombectomized PTFE at the arterial end and the silastic venous end is replaced percutaneously via Seldinger technique or “open technique”.
The end result of the above advantages translates into superior patency rates and a decreased complication rate with this new system. Patients are spared the repeated painful hospitalizations for failed access as well as the emotional trauma associated with this difficult condition. The physicians are spared the dilemma of how to best treat these patients. This system will have a large impact on the current practice of vascular access in areas such as hemodialysis; plasmapheresis; chemotherapy; hyperalimentation; and chronic blood draws.
While the invention has been explained by a detailed description of certain specific embodiments, it is understood that various modifications and substitutions can be made in any of them within the scope of the appended claims which are intended also to include equivalents of such embodiments.

Claims (51)

1. A Squitieri hemodialysis and vascular access system to shunt blood between a vein and an artery the system comprising:
(a) a first tube having a first end adapted to be connected to the artery and a second end;
(b) a second tube having a first end adapted to be connected to the vein and including a plurality of apertures extending therethrough and having a second end; and
(c) a needle access port having a frame including a conduit extending therethrough, said frame having an inlet connected to the second end of the first tube and an outlet connected to the second end of the second tube to provide a flow path for blood and a silicone member protruding from the frame to provide access for needles into the flow path, wherein the needle access port includes:
an outer frame member having an upper surface including an aperture extending therethrough and downwardly extending walls about its periphery having inlet and outlet apertures, wherein the upper surface includes a lower portion having a plurality of teeth;
a silicone member mounted within the frame having a surface engaged by the frame teeth and an upwardly protruding portion extending through the frame aperture; and
a second frame member having a transverse conduit extending between the inlet and outlet apertures, an upper surface having a plurality of teeth engaging the silicone member to effect a seal and wherein the second frame member is positioned within the walls of the first frame member.
2. The Squitieri hemodialysis and vascular access system of claim 1, wherein:
the first tube corresponds to PTFE tubing;
the second tube corresponds to silicone tubing; and
the protruding silicone member has an oval configuration.
3. The Squitieri hemodialysis and vascular access system of claim 1, wherein the first tube includes rings mounted thereabout to provide additional strength.
4. The Squitieri hemodialysis and vascular access system of claim 1 further comprising:
a second needle access port having an inlet and an outlet and silastic silicone tubing coupling the inlet of the second needle access port to the outlet of the other needle access port and wherein the outlet of the second access port is coupled to the second end of the second tube.
5. The Squitieri hemodialysis and vascular access system of claim 1 wherein:
the first tube is provided as PTFE tubing which is adapted for attachment to the artery at one end and coupled to the access port at the other end; and
the second tube is provided as silicone tubing which is coupled to the needle access port at one end and is capable of being floated within the vein at the other end.
6. The Squitieri hemodialysis and vascular access system of claim 1, wherein:
the first tube is inserted within an outer silicone tubing at the inlet to the needle access port.
7. The Squitieri hemodialysis and vascular access system of claim 1, further including:
an adjustable band mounted about the first tube at the inlet to the needle access port to regulate blood flow.
8. The Squitieri hemodialysis and vascular access system of claim 4, wherein:
a second needle access port is mounted to the needle access port, said ports having a single frame and a conduit extending longitudinally therethrough to the outlet tubing.
9. A Squitieri hemodialysis and vascular access system to shunt blood between a vein and an artery, the system including:
(a) a first tube having a first end adapted to be connected to the artery;
(b) a second tube having a first end adapted to be connected to the vein and including a plurality of apertures extending therethrough and having a second end;
(c) a needle access port having a frame including a conduit extending therethrough, said frame having an inlet connected to the second end of the first tube and an outlet connected to the second end of the second tube to provide a flow path for blood and a silicone member protruding from the frame to provide access for needles into the flow path; and
a quick coupler for joining the first tube to the needle access port comprising a port member projecting outwardly from the frame inlet and having a circumferential slot extending thereabout, a cooperating member having an outer portion extending concentrically with the first tube and a portion extending outwardly therefrom and an outwardly sloped portion extending over the projecting port member and having an inner circumferential projection which engages the circumferential slot, and wherein the first tube extends over the port member to be engaged by the projecting portion of the cooperating member within the slot and a removable coupling which snaps over the cooperating member forcing it into a sealed engagement with the port member.
10. A Squitieri hemodialysis and vascular access system to shunt blood between a vein and an artery, the system including:
(a) a first tube having a first end adapted to be connected to the artery;
(b) a second tube having a first end adapted to be connected to the vein and including a plurality of apertures extending therethrough and having a second end; and
(c) a needle access port having a frame including a conduit extending therethrough, said frame having an inlet connected to the second end of the first tube and an outlet connected to the second end of the second tube to provide a flow path for blood and a silicone member protruding from the frame to provide access for needles into the flow path, wherein the needle access port comprises:
a first member having a base, walls extending upwardly therefrom to form an enclosed area, and outwardly extending couplings on opposite walls thereof at the inlet and outlet of said port;
a second member having a top including an upper aperture, downwardly extending side walls engaging the walls of the first member and having a conduit extending from the inlet to the outlet and a silicone member projecting form the upper aperture to provide needle access; and
a tube mounted over each coupling and a coupler which fits over each tube to seal the tubes to the couplings.
11. The Squitieri hemodialysis and vascular access system of claim 1, wherein:
the second tube is capable of being floated within a vein at the one end and the plurality of apertures in the second tube are distant from the site where the second tube is inserted into the vein, said second tube not being fixed to the vein wall.
12. A hemodialysis and vascular access system comprising:
an arterialized indwelling venous catheter having a graft section provided from a material which is biocompatible with an artery, has a nonthrombogenic characteristic, which is adapted for long term attachment to an artery and which includes a region for repeated needle access and a catheter section, with a first end of said graft section adapted to be coupled to an artery and a portion of the catheter section adapted to be inserted within a vein at an insertion site, said catheter section portion having at least one opening in an end thereof with at least one of the at least one openings in the catheter section portion adapted to be within the vein itself and wherein the at least one opening is distant from the insertion site such that blood flows from the artery through the catheter and is returned to the vein through the at least one opening while providing laminar blood flow between the artery and the vein.
13. The hemodialysis and vascular access system of claim 12, further comprising:
at least one needle having a first end coupled to a hemodialysis device and having a second end adapted for insertion directly into said graft section of the catheter to shunt the blood flow through the dialysis device.
14. The hemodialysis and vascular access system of claim 13 wherein said graft section is provided from a first tube and said catheter section is provided from a second tube comprising multiple layers and a first end of said first tube is coupled to a first end of said second tube.
15. The hemodialysis and vascular access system of claim 14 wherein said first and second tubes are adapted for percutaneously placement.
16. The hemodialysis and vascular access system of claim 14 wherein the end of said second tube which is coupled to the first tube includes an enlarged portion in which the first end of said first tube is disposed.
17. A hemodialysis and vascular access system, comprising:
an arterialized indwelling venous catheter having a graft section provided from a material which is biocompatible with an artery, has a nonthrombogenic characteristic, which is adapted for long term attachment to an artery and which includes a region of repeated needle access and a catheter section, with a first end of said first graft section adapted to be coupled to an artery and a portion of the catheter section adapted to be inserted within a vein at an insertion site, said catheter section portion having an outside diameter which is less than an inner diameter of the vein and having at least one opening in an end thereof with at least one of the at least one openings in the catheter section portion adapted to be within the vein itself and wherein the at least one opening is distant from the insertion site such that, in operation, blood flows from the artery through the catheter and is returned to the vein through the at least one opening while providing laminar blood flow between the artery and the vein and blood also flows through the vein uninterrupted around at least an outer portion of said catheter; and
at least one needle having a first end coupled to a hemodialysis device and having a second end adapted for insertion directly into the arterialized indwelling venous catheter to shunt the blood flow through the dialysis device.
18. The hemodialysis and vascular access system of claim 17 wherein the graft section of said arterialized indwelling venous catheter is provided from a first tube and said catheter section is provided from a second tube comprising multiple layers and a first end of said first tube is coupled to a first end of said second tube.
19. The hemodialysis and vascular access system of claim 18 wherein said first and second tubes are adapted for percutaneous placement.
20. The hemodialysis and vascular access system of claim 18 wherein the end of said second tube which is coupled to the first tube includes an enlarged portion in which the first end of said first tube is disposed.
21. A hemodialysis and vascular access system as in claim 17, wherein the graft section comprises PTFE.
22. A hemodialysis and vascular access system as in claim 17, wherein the graft section comprises polyethylene terephthalate.
23. A hemodialysis and vascular access system as in claim 17, wherein the graft section has a diameter of approximately 7 mm.
24. A hemodialysis and vascular access system as in claim 17, wherein the first end of the graft section has a diameter of about 4 mm.
25. A hemodialysis and vascular access system as in claim 17, wherein the catheter section comprises silicone.
26. A hemodialysis and vascular access system as in claim 17, wherein a downstream end of the catheter section is provided with a bevel.
27. A hemodialysis and vascular access system as in claim 17, additionally comprising an access segment for receiving a needle to allow access to blood flowing through the catheter.
28. A hemodialysis and vascular access system as in claim 27, wherein the access segment comprises a self sealing material.
29. A hemodialysis and vascular access system as in claim 28, wherein the self sealing material comprises silicone.
30. A hemodialysis and vascular access system as in claim 28, wherein the access segment is removably connected to the access system.
31. A hemodialysis and vascular access system as in claim 27, further comprising a support structure in the access segment.
32. A hemodialysis and vascular access system as in claim 31, wherein the support structure comprises a frame.
33. A hemodialysis and vascular access system as in claim 31, wherein the support structure comprises ridges.
34. A hemodialysis and vascular access system as in claim 33, wherein the ridges comprise teeth.
35. A hemodialysis and vascular access system as in claim 17, wherein at least a portion of the indwelling venous catheter comprises multiple layers.
36. A hemodialysis and vascular access system as in claim 35, wherein the multiple layers comprise a first PTFE layer and a second silicone layer.
37. A hemodialysis and vascular access system as in claim 36, wherein the first PTFE layer is an inner PTFE layer and the second silicone layer is an outer silicone layer.
38. A hemodialysis and vascular access system as in claim 37, wherein the multiple layers further comprises a PTFE coating on the outer silicone layer.
39. A hemodialysis and vascular access system as in claim 17, wherein said graft section and said catheter section comprise a material selected from the group consisting of PTFE, silicone, or flexible plastic.
40. A hemodialysis and vascular access system as in claim 17, comprising first and second needle access sites.
41. A hemodialysis and vascular access system as in claim 17, wherein the catheter section comprises a long, flexible plastic tube.
42. A hemodialysis and vascular access system as in claim 17, wherein the region for repeated needle access comprises needle receiving sites(s) and comprises an internal chamber that is tubular in shape.
43. A hemodialysis and vascular access system as in claim 17, wherein the region for repeated needle access comprises a self-sealing material.
44. A hemodialysis and vascular access system as in claim 17, wherein the catheter section comprises a silicone section.
45. A hemodialysis and vascular access system as in claim 44, wherein the silicone section is lined with PTFE.
46. A hemodialysis and vascular access system as in claim 17, wherein the region of repeated needle access comprises multiple layers.
47. A hemodialysis and vascular access system as in claim 46, wherein the multiple layers comprise PTFE on the inside and silicone on the outside.
48. A hemodialysis and vascular access system as in claim 46, wherein the multiple layers comprise PTFE on the inside and silicone disposed outside of the PTFE.
49. A hemodialysis and vascular access system as in claim 17, wherein the material providing the graft section comprises a thrombus resistant coating.
50. A hemodialysis and vascular access system as in claim 49, wherein the thrombus resistant coating comprises heparin.
51. A hemodialysis and vascular access system as in claim 17, wherein a nonthrombenic characteristic is provided by continuous flow of blood through at least the graft section.
US10/219,998 1997-02-07 2002-08-15 Squitieri hemodialysis and vascular access systems Expired - Lifetime USRE41448E1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/219,998 USRE41448E1 (en) 1997-02-07 2002-08-15 Squitieri hemodialysis and vascular access systems
US11/417,658 US20070123811A1 (en) 1997-02-07 2006-05-03 Squitieri hemodialysis and vascular access systems
US12/688,716 USRE44639E1 (en) 1997-02-07 2010-01-15 Hemodialysis and vascular access system

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3709497P 1997-02-07 1997-02-07
US08/835,316 US6102884A (en) 1997-02-07 1997-04-07 Squitieri hemodialysis and vascular access systems
US10/219,998 USRE41448E1 (en) 1997-02-07 2002-08-15 Squitieri hemodialysis and vascular access systems

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US08/835,316 Reissue US6102884A (en) 1997-02-07 1997-04-07 Squitieri hemodialysis and vascular access systems

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US08/835,316 Continuation US6102884A (en) 1997-02-07 1997-04-07 Squitieri hemodialysis and vascular access systems
US11/417,658 Continuation US20070123811A1 (en) 1997-02-07 2006-05-03 Squitieri hemodialysis and vascular access systems

Publications (1)

Publication Number Publication Date
USRE41448E1 true USRE41448E1 (en) 2010-07-20

Family

ID=26713805

Family Applications (5)

Application Number Title Priority Date Filing Date
US08/835,316 Ceased US6102884A (en) 1997-02-07 1997-04-07 Squitieri hemodialysis and vascular access systems
US09/490,368 Expired - Lifetime US6582409B1 (en) 1997-02-07 2000-01-24 Hemodialysis and vascular access systems
US10/219,998 Expired - Lifetime USRE41448E1 (en) 1997-02-07 2002-08-15 Squitieri hemodialysis and vascular access systems
US11/417,658 Abandoned US20070123811A1 (en) 1997-02-07 2006-05-03 Squitieri hemodialysis and vascular access systems
US12/688,716 Expired - Lifetime USRE44639E1 (en) 1997-02-07 2010-01-15 Hemodialysis and vascular access system

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US08/835,316 Ceased US6102884A (en) 1997-02-07 1997-04-07 Squitieri hemodialysis and vascular access systems
US09/490,368 Expired - Lifetime US6582409B1 (en) 1997-02-07 2000-01-24 Hemodialysis and vascular access systems

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11/417,658 Abandoned US20070123811A1 (en) 1997-02-07 2006-05-03 Squitieri hemodialysis and vascular access systems
US12/688,716 Expired - Lifetime USRE44639E1 (en) 1997-02-07 2010-01-15 Hemodialysis and vascular access system

Country Status (6)

Country Link
US (5) US6102884A (en)
EP (2) EP1550479B1 (en)
JP (1) JP3995057B2 (en)
AU (1) AU6053498A (en)
DE (1) DE69829468T2 (en)
WO (1) WO1998034676A1 (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8079973B2 (en) 2008-03-05 2011-12-20 Hemosphere Inc. Vascular access system
USRE44639E1 (en) 1997-02-07 2013-12-10 Hemosphere, Inc. Hemodialysis and vascular access system
US8690815B2 (en) 2003-10-08 2014-04-08 Hemosphere, Inc. Device and method for vascular access
US9278172B2 (en) 2011-09-06 2016-03-08 Cryolife, Inc. Vascular access system with connector
US10004842B2 (en) 2011-08-11 2018-06-26 Medical Components, Inc. Method and apparatus for the dialysis of blood
US10682453B2 (en) 2013-12-20 2020-06-16 Merit Medical Systems, Inc. Vascular access system with reinforcement member
US10792413B2 (en) 2008-03-05 2020-10-06 Merit Medical Systems, Inc. Implantable and removable customizable body conduit
USD905853S1 (en) 2018-02-27 2020-12-22 Medical Components, Inc. Catheter tip
US10925710B2 (en) 2017-03-24 2021-02-23 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
US11026704B2 (en) 2017-03-06 2021-06-08 Merit Medical Systems, Inc. Vascular access assembly declotting systems and methods
US11116943B2 (en) 2018-10-09 2021-09-14 Limflow Gmbh Methods for accessing pedal veins
US11179543B2 (en) 2017-07-14 2021-11-23 Merit Medical Systems, Inc. Releasable conduit connectors
US11241304B2 (en) 2006-04-20 2022-02-08 Limflow Gmbh Method for fluid flow through body passages
US11331458B2 (en) 2017-10-31 2022-05-17 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
US11383072B2 (en) 2017-01-12 2022-07-12 Merit Medical Systems, Inc. Methods and systems for selection and use of connectors between conduits
US11413043B2 (en) 2016-11-10 2022-08-16 Merit Medical Systems, Inc. Anchor device for vascular anastomosis
US11446170B2 (en) 2004-09-08 2022-09-20 Limflow Gmbh Minimally invasive surgical apparatus and methods
US11471262B2 (en) 2013-03-08 2022-10-18 Limflow Gmbh Methods for targeting a body passage to effect fluid flow
US11590010B2 (en) 2017-01-25 2023-02-28 Merit Medical Systems, Inc. Methods and systems for facilitating laminar flow between conduits
US11612397B2 (en) 2019-11-01 2023-03-28 Limflow Gmbh Devices and methods for increasing blood perfusion to a distal extremity
USD984880S1 (en) 2020-11-06 2023-05-02 Medical Components, Inc. Clamp with indicator
US11826504B2 (en) 2017-04-10 2023-11-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US11911585B2 (en) 2017-07-20 2024-02-27 Merit Medical Systems, Inc. Methods and systems for coupling conduits

Families Citing this family (134)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2245897C (en) 1996-02-28 2004-12-14 Impra, Inc. Flanged graft for end-to-side anastomosis
GB9709967D0 (en) * 1997-05-17 1997-07-09 Harris Peter L Prosthetic grafts
US6090118A (en) 1998-07-23 2000-07-18 Mcguckin, Jr.; James F. Rotational thrombectomy apparatus and method with standing wave
US6889082B2 (en) 1997-10-09 2005-05-03 Orqis Medical Corporation Implantable heart assist system and method of applying same
US6603112B1 (en) * 1998-02-25 2003-08-05 Massachusetts Institute Of Technology Method and apparatus for detecting malfunctions in communication systems
US8177762B2 (en) 1998-12-07 2012-05-15 C. R. Bard, Inc. Septum including at least one identifiable feature, access ports including same, and related methods
US6338724B1 (en) 1999-03-29 2002-01-15 Christos D. Dossa Arterio-venous interconnection
US9814869B1 (en) * 1999-06-15 2017-11-14 C.R. Bard, Inc. Graft-catheter vascular access system
WO2001026713A1 (en) * 1999-10-12 2001-04-19 Biolink Corporation Single needle vascular access for home hemodialysis
US6544206B1 (en) * 1999-10-14 2003-04-08 Robert H. Johnston, Jr. Dialysis access system and method
US8414543B2 (en) 1999-10-22 2013-04-09 Rex Medical, L.P. Rotational thrombectomy wire with blocking device
AU2614901A (en) 1999-10-22 2001-04-30 Boston Scientific Corporation Double balloon thrombectomy catheter
US7131959B2 (en) * 2003-01-23 2006-11-07 Integrated Vascular Interventional Technologies, L.C., (“IVIT LC”) Apparatus and methods for occluding an access tube anastomosed to sidewall of an anatomical vessel
US6656151B1 (en) 2000-01-11 2003-12-02 Integrated Vascular Interventional Technologies, L.C. (Ivit, Lc) Vascular access devices and systems
AU2001229433A1 (en) 2000-01-11 2001-07-24 Duane D. Blatter Vascular occlusal balloons and related vascular access devices and systems
US7118546B2 (en) * 2000-01-11 2006-10-10 Integrated Vascular Interventional Technologies, L.C. Apparatus and methods for facilitating repeated vascular access
US6595941B1 (en) * 2000-01-11 2003-07-22 Integrated Vascular Interventional Technologies, L.C. Methods for external treatment of blood
US6773428B2 (en) * 2000-05-12 2004-08-10 Stephen M. Zappala Implantable delivery system and method for the pharmacologic management of erectile dysfunction
JP4967183B2 (en) * 2000-09-22 2012-07-04 株式会社ジェイ・エム・エス Blood collection device for arterial or venous line blood collection system, and arterial or venous line blood collection system using the blood collection device.
US6761700B2 (en) * 2001-02-09 2004-07-13 Orqis Medical Corporation Extra-corporeal vascular conduit
US7101356B2 (en) * 2001-03-23 2006-09-05 Miller Stuart H Implantable vascular access device
US6997914B2 (en) * 2001-04-02 2006-02-14 Horizon Medical Products, Inc. Implantable access port
WO2003000314A2 (en) * 2001-06-20 2003-01-03 The Regents Of The University Of California Hemodialysis system and method
US7481936B2 (en) * 2001-10-17 2009-01-27 Transvivo Inc. Method and apparatus for patient fluid management
US6899692B2 (en) * 2001-10-17 2005-05-31 Transvivo, Inc. Plasmapheresis filter device and catheter assembly
US6849183B2 (en) * 2002-08-13 2005-02-01 Transvivo, Inc. Method and apparatus for therapeutic apheresis
US7261705B2 (en) * 2002-10-09 2007-08-28 Circuport, Inc. Implantable dialysis access port
US8574204B2 (en) 2002-10-21 2013-11-05 Angiodynamics, Inc. Implantable medical device for improved placement and adherence in the body
US20060142633A1 (en) * 2002-12-17 2006-06-29 Lane Rodney J Blood pumping system and procedure
US7124570B2 (en) * 2003-01-23 2006-10-24 Integrated Vascular Interventional Technologies, L.C. Apparatus and methods for fluid occlusion of an access tube anastomosed to an anatomical vessel
US7967769B2 (en) 2003-04-08 2011-06-28 Rox Medical Inc. Implantable arterio-venous shunt devices and methods for their use
US20040249335A1 (en) * 2003-04-08 2004-12-09 Faul John L. Implantable arteriovenous shunt device
US7452374B2 (en) * 2003-04-24 2008-11-18 Maquet Cardiovascular, Llc AV grafts with rapid post-operative self-sealing capabilities
US7025741B2 (en) * 2003-06-06 2006-04-11 Creativasc Medical Llc Arteriovenous access valve system and process
US8114044B2 (en) * 2003-06-06 2012-02-14 Creativasc Medical, Llc Arteriovenous access valve system and process
US20050137614A1 (en) * 2003-10-08 2005-06-23 Porter Christopher H. System and method for connecting implanted conduits
US20050203457A1 (en) * 2004-03-15 2005-09-15 Smego Douglas R. Apparatus and method for creating an arterio-venous connection in hemodialysis maintenance
US8747344B2 (en) * 2004-03-29 2014-06-10 Nazir A. Khan Hybrid arteriovenous shunt
US8282591B2 (en) * 2004-03-29 2012-10-09 Iftikhar Khan Hybrid arteriovenous shunt
US8177760B2 (en) 2004-05-12 2012-05-15 C. R. Bard, Inc. Valved connector
US20060004316A1 (en) 2004-07-02 2006-01-05 Difiore Attilio E Reduction of recirculation in catheters
EP1791496B1 (en) * 2004-08-31 2019-07-31 C.R. Bard, Inc. Self-sealing ptfe graft with kink resistance
US20080118561A1 (en) * 2004-12-08 2008-05-22 Helen Marie Nugent Materials and Methods for Minimally-Invasive Administration of a Cell-Containing Flowable Composition
US8029482B2 (en) 2005-03-04 2011-10-04 C. R. Bard, Inc. Systems and methods for radiographically identifying an access port
US9474888B2 (en) 2005-03-04 2016-10-25 C. R. Bard, Inc. Implantable access port including a sandwiched radiopaque insert
US7947022B2 (en) 2005-03-04 2011-05-24 C. R. Bard, Inc. Access port identification systems and methods
WO2006096686A1 (en) 2005-03-04 2006-09-14 C.R. Bard, Inc. Access port identification systems and methods
US8147455B2 (en) 2005-04-27 2012-04-03 C. R. Bard, Inc. Infusion apparatuses and methods of use
EP1896117B1 (en) 2005-04-27 2011-01-12 C.R.Bard, Inc. Power injector system for injecting contrast media into an intravenous line
US10307581B2 (en) 2005-04-27 2019-06-04 C. R. Bard, Inc. Reinforced septum for an implantable medical device
US7794422B2 (en) * 2005-05-27 2010-09-14 Medical Components, Inc. Catheter port assembly for extracorporeal treatment
PT1890641T (en) 2005-06-17 2017-05-30 Bard Inc C R Vascular graft with kink resistance after clamping
US8709069B2 (en) 2005-07-01 2014-04-29 C. R. Bard, Inc. Flanged graft with trim lines
US20070073250A1 (en) * 2005-07-08 2007-03-29 Schneiter James A Implantable port
CA2626598A1 (en) 2005-11-09 2007-05-18 C.R. Bard Inc. Grafts and stent grafts having a radiopaque marker
US8163002B2 (en) * 2005-11-14 2012-04-24 Vascular Devices Llc Self-sealing vascular graft
US20070167901A1 (en) * 2005-11-17 2007-07-19 Herrig Judson A Self-sealing residual compressive stress graft for dialysis
US9198749B2 (en) 2006-10-12 2015-12-01 C. R. Bard, Inc. Vascular grafts with multiple channels and methods for making
WO2008051391A2 (en) * 2006-10-23 2008-05-02 Rex Medical, L.P. Vascular conduit
US9642986B2 (en) 2006-11-08 2017-05-09 C. R. Bard, Inc. Resource information key for an insertable medical device
US9265912B2 (en) 2006-11-08 2016-02-23 C. R. Bard, Inc. Indicia informative of characteristics of insertable medical devices
US20080306580A1 (en) * 2007-02-05 2008-12-11 Boston Scientific Scimed, Inc. Blood acess apparatus and method
WO2008097946A2 (en) * 2007-02-05 2008-08-14 Boston Scientific Scimed, Inc. Expandable dialysis apparatus and method
FR2915107A1 (en) * 2007-04-20 2008-10-24 Braun Medical Sas Soc Par Acti SEPTUM OF IMPLANTABLE ROOM, AND IMPLANTABLE ROOM COMPRISING IT
US20080300528A1 (en) * 2007-05-29 2008-12-04 Creativasc Medical Llc Arteriovenous access valve system and process
US20090030498A1 (en) 2007-05-29 2009-01-29 Creativasc Medical Arteriovenous Access Valve System and Process
US8257325B2 (en) 2007-06-20 2012-09-04 Medical Components, Inc. Venous access port with molded and/or radiopaque indicia
EP2180915B1 (en) 2007-07-19 2017-10-04 Medical Components, Inc. Venous access port assembly with x-ray discernable indicia
US9610432B2 (en) 2007-07-19 2017-04-04 Innovative Medical Devices, Llc Venous access port assembly with X-ray discernable indicia
WO2009035582A1 (en) * 2007-09-07 2009-03-19 Angiodynamics, Inc. Implantable access port
WO2009033177A1 (en) * 2007-09-07 2009-03-12 Imtec, Llc Method and device for dialysis
AU2008308451A1 (en) * 2007-10-05 2009-04-09 Angiodynamics, Inc. Dual reservoir implantable access port
US9579496B2 (en) 2007-11-07 2017-02-28 C. R. Bard, Inc. Radiopaque and septum-based indicators for a multi-lumen implantable port
US20100280598A1 (en) * 2007-12-27 2010-11-04 C.R. Bard, Inc. Vascular graft prosthesis having a reinforced margin for enhanced anastomosis
US20090192469A1 (en) * 2008-01-24 2009-07-30 Istvan Bognar Devices and Methods for Development of a Scar Tissue Tunnel Track
EP4088772A1 (en) * 2008-01-28 2022-11-16 Implantica Patent Ltd. A drainage device
US20100010339A1 (en) * 2008-03-13 2010-01-14 Smith Christopher K Method and device for easy access to subintimally implanted vascular access ports
US20090234267A1 (en) * 2008-03-13 2009-09-17 Ross John R Method and device for easy access to vascular graft cannulation sites
US8409228B2 (en) 2008-06-06 2013-04-02 Duane D. Blatter Tissue management methods, apparatus, and systems
US8075531B2 (en) * 2008-07-16 2011-12-13 Marvao Medical Ltd. Modular implantable medical device
US20100030322A1 (en) * 2008-07-30 2010-02-04 John Sang Hun Lee Bridge graft
WO2010015001A1 (en) * 2008-08-01 2010-02-04 The Methodist Hospital Research Institute Hemodialysis grafts and methods for localizing and identifying the placement of same
WO2010028272A1 (en) * 2008-09-05 2010-03-11 Imtecbiomedical, Inc. Method and apparatus for vascular access
US20100152640A1 (en) * 2008-09-05 2010-06-17 Imtecbiomedical, Inc. Methods and apparatus for vascular access
WO2010039862A1 (en) * 2008-09-30 2010-04-08 Rox Medical, Inc. Methods for screening and treating patients with compromised cardiopulmonary function
WO2010051494A1 (en) 2008-10-31 2010-05-06 C.R. Bard, Inc. Systems and methods for identifying an acess port
US8932271B2 (en) 2008-11-13 2015-01-13 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US11890443B2 (en) 2008-11-13 2024-02-06 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US11197952B2 (en) 2009-01-29 2021-12-14 Advent Access Pte. Ltd. Vascular access ports and related methods
US9179901B2 (en) * 2009-01-29 2015-11-10 Vital Access Corporation Vascular access ports and related methods
JP5829125B2 (en) 2009-01-29 2015-12-09 ヴァイタル アクセス コーポレイションVital Access Corporation Vascular access port and method related thereto
WO2011005812A2 (en) * 2009-07-07 2011-01-13 Marwan Tabbara Surgical methods, devices, and kits
US20140155804A1 (en) * 2009-07-07 2014-06-05 Marwan Tabbara Surgical devices and kits
EP2451512A1 (en) 2009-07-07 2012-05-16 C.R. Bard Inc. Extensible internal bolster for a medical device
KR101037077B1 (en) 2009-09-25 2011-05-26 주식회사 리브라하트 A conduit which is capable of attaching and detaching Ventricular Assist Device and its using method
JP2013510652A (en) 2009-11-17 2013-03-28 シー・アール・バード・インコーポレーテッド Overmolded access port including locking feature and identification feature
ES2793478T3 (en) 2010-03-09 2020-11-16 Solinas Medical Inc Automatic closing devices
US20110226253A1 (en) * 2010-03-16 2011-09-22 Exclusive Computer Innovations, Llc Cough shield
USD682416S1 (en) 2010-12-30 2013-05-14 C. R. Bard, Inc. Implantable access port
USD676955S1 (en) 2010-12-30 2013-02-26 C. R. Bard, Inc. Implantable access port
WO2012103328A1 (en) 2011-01-26 2012-08-02 The Methodist Hospital Research Institute Labeled, non- peptidic multivalent integrin alpha -v - beta - 3 antagonists, compositions containing them and their use
CA2829766C (en) 2011-03-16 2019-07-02 Shawn M. GAGE Arteriovenous graft for hemodialysis with puncture-resistant posterior and side walls
US8882694B2 (en) 2011-06-03 2014-11-11 The Johns Hopkins University Implantable three-way diaphragm valve
JP5869252B2 (en) * 2011-07-29 2016-02-24 川澄化学工業株式会社 Vascular access device
US9707339B2 (en) 2012-03-28 2017-07-18 Angiodynamics, Inc. High flow rate dual reservoir port system
US9713704B2 (en) 2012-03-29 2017-07-25 Bradley D. Chartrand Port reservoir cleaning system and method
US9205242B2 (en) 2012-11-19 2015-12-08 Angiodynamics, Inc. Port septum with integral valve
US11420033B2 (en) 2013-01-23 2022-08-23 C. R. Bard, Inc. Low-profile single and dual vascular access device
JP6487339B2 (en) 2013-01-23 2019-03-20 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Low profile access port
US11464960B2 (en) 2013-01-23 2022-10-11 C. R. Bard, Inc. Low-profile single and dual vascular access device
US10835367B2 (en) 2013-03-08 2020-11-17 Limflow Gmbh Devices for fluid flow through body passages
CN105517512B (en) 2013-04-13 2019-01-22 索利纳斯医疗公司 Self-closing device and device and method for manufacturing and conveying self-closing device
WO2015009681A2 (en) 2013-07-18 2015-01-22 Cryolife, Inc. Vascular access system with connector
WO2015023460A1 (en) 2013-08-13 2015-02-19 Cryolife, Inc. Systems and methods for a fluid carrying conduit of a vascular access system
US10166321B2 (en) 2014-01-09 2019-01-01 Angiodynamics, Inc. High-flow port and infusion needle systems
ES2880334T3 (en) 2014-03-07 2021-11-24 Bard Inc C R Stabilization and Guidance Appliance for Access to an Implanted Pathway and Related Methods
US9895149B2 (en) * 2014-04-25 2018-02-20 Diaxamed, Llc Magnetically activated arteriovenous access valve system and related methods
JP2015213594A (en) * 2014-05-09 2015-12-03 ニプロ株式会社 Blood vessel access device
US9545263B2 (en) 2014-06-19 2017-01-17 Limflow Gmbh Devices and methods for treating lower extremity vasculature
WO2016179457A1 (en) * 2015-05-06 2016-11-10 Scepter Medical Devices Llc Vascular access channel and methods
EP3307374A4 (en) 2015-06-11 2019-04-10 Proviflo, LLC Graft-port hemodialysis systems, devices and methods
EP3448311A4 (en) 2016-04-25 2020-01-01 Solinas Medical, Inc. Self-sealing tubular grafts, patches, and methods for making and using them
CN106938064B (en) * 2017-03-02 2023-11-24 南华大学附属第二医院 Puncture hemodialysis catheter
CN106730083A (en) * 2017-03-14 2017-05-31 周峻 A kind of subcutaneous implantable delivery system hemodialysis catheter
WO2018183854A1 (en) 2017-03-31 2018-10-04 InnAVasc Medical, Inc. Apparatus and method for cannulation of vascular access graft
US10406274B1 (en) 2017-06-02 2019-09-10 Jose Ramirez Accessing assembly for hemodialysis administration
CN107376043A (en) * 2017-08-24 2017-11-24 范朕 A kind of implantable subcutaneous vascular access punctures valve
USD870264S1 (en) 2017-09-06 2019-12-17 C. R. Bard, Inc. Implantable apheresis port
EP3743005A4 (en) 2018-01-26 2021-04-14 Bard Peripheral Vascular, Inc. Systems and methods for locating and identifying an implanted medical device
CN109107020A (en) * 2018-09-18 2019-01-01 中山肾康医疗科技有限公司 A kind of subcutaneous embedded sting device for haemodialysis artery and vein puncture
CN109260570A (en) * 2018-09-18 2019-01-25 中山肾康医疗科技有限公司 A kind of subcutaneous embedded sting device for hemodialysis catheter
US11925781B2 (en) 2018-10-30 2024-03-12 InnAVasc Medical, Inc. Apparatus and method for cannulation of vascular access vessel
DE102018133404A1 (en) 2018-12-21 2020-06-25 B.Braun Avitum Ag Vascular access implant and access implant system
WO2024007921A1 (en) * 2022-07-05 2024-01-11 上海心光生物医药有限责任公司 Implantable access device and fluid circulation system

Citations (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683926A (en) * 1970-07-09 1972-08-15 Dainippon Pharmaceutical Co Tube for connecting blood vessels
US3818511A (en) 1972-11-17 1974-06-25 Medical Prod Corp Medical prosthesis for ducts or conduits
US3882862A (en) 1974-01-11 1975-05-13 Olga Berend Arteriovenous shunt
JPS5714358A (en) 1980-07-02 1982-01-25 Toray Industries Antithrombus medical material
US4318401A (en) * 1980-04-24 1982-03-09 President And Fellows Of Harvard College Percutaneous vascular access portal and catheter
JPS58168333A (en) 1982-03-29 1983-10-04 Fujitsu Ltd Phase comparing system of phase locking loop circuit
US4447237A (en) 1982-05-07 1984-05-08 Dow Corning Corporation Valving slit construction and cooperating assembly for penetrating the same
WO1984003036A1 (en) 1983-02-03 1984-08-16 Wallsten Hans Ivar Blood vessel prosthesis
US4496349A (en) 1981-05-08 1985-01-29 Renal Systems, Inc. Percutaneous implant
US4619641A (en) 1984-11-13 1986-10-28 Mount Sinai School Of Medicine Of The City University Of New York Coaxial double lumen anteriovenous grafts
US4822341A (en) * 1987-11-20 1989-04-18 Impra, Inc. Vascular access fistula
US4877661A (en) 1987-10-19 1989-10-31 W. L. Gore & Associates, Inc. Rapidly recoverable PTFE and process therefore
US4898669A (en) * 1987-06-16 1990-02-06 Claber S.P.A. Vascular access device, in particular for purification treatments of the blood
US4929236A (en) * 1988-05-26 1990-05-29 Shiley Infusaid, Inc. Snap-lock fitting catheter for an implantable device
US4955899A (en) 1989-05-26 1990-09-11 Impra, Inc. Longitudinally compliant vascular graft
US5041098A (en) 1989-05-19 1991-08-20 Strato Medical Corporation Vascular access system for extracorporeal treatment of blood
US5192310A (en) * 1991-09-16 1993-03-09 Atrium Medical Corporation Self-sealing implantable vascular graft
US5197976A (en) * 1991-09-16 1993-03-30 Atrium Medical Corporation Manually separable multi-lumen vascular graft
JPH05212107A (en) 1991-09-07 1993-08-24 Hans Haindl Port catheter
JPH06105798A (en) 1992-09-30 1994-04-19 Terumo Corp Catheter tube
US5399168A (en) * 1991-08-29 1995-03-21 C. R. Bard, Inc. Implantable plural fluid cavity port
WO1995019200A1 (en) 1994-01-18 1995-07-20 Finch Charles David Jr Implantable vascular device
DE4418910A1 (en) 1994-05-31 1995-12-07 Mouhamed Kamal Dr Med Koudaimi Dialysis port system and diaphragm
US5476451A (en) * 1990-03-01 1995-12-19 Michigan Transtech Corporation Implantable access devices
WO1996024399A1 (en) 1995-02-09 1996-08-15 The Curators Of The University Of Missouri Clot resistant multiple lumen catheter
US5558641A (en) * 1994-01-24 1996-09-24 Sims Deltec, Inc. Hybrid portal and method
US5562618A (en) * 1994-01-21 1996-10-08 Sims Deltec, Inc. Portal assembly and catheter connector
US5591226A (en) 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
DE29515546U1 (en) 1995-09-29 1997-01-30 Schreiber Hans Vascular port, especially for hemodialysis
US5607463A (en) 1993-03-30 1997-03-04 Medtronic, Inc. Intravascular medical device
JPH0984871A (en) 1995-09-25 1997-03-31 Terumo Corp Medical tube and manufacture thereof
US5637102A (en) * 1995-05-24 1997-06-10 C. R. Bard, Inc. Dual-type catheter connection system
US5637088A (en) * 1995-09-14 1997-06-10 Wenner; Donald E. System for preventing needle displacement in subcutaneous venous access ports
US5676346A (en) * 1995-05-16 1997-10-14 Ivac Holdings, Inc. Needleless connector valve
US5743894A (en) * 1995-06-07 1998-04-28 Sherwood Medical Company Spike port with integrated two way valve access
US5792104A (en) * 1996-12-10 1998-08-11 Medtronic, Inc. Dual-reservoir vascular access port
US5797879A (en) * 1996-08-26 1998-08-25 Decampli; William M. Apparatus and methods for providing selectively adjustable blood flow through a vascular graft
US5800512A (en) 1996-01-22 1998-09-01 Meadox Medicals, Inc. PTFE vascular graft
US5830224A (en) * 1996-03-15 1998-11-03 Beth Israel Deaconess Medical Center Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo
US5840240A (en) 1991-11-04 1998-11-24 Possis Medical, Inc. Method of making a silicone composite vascular graft
US5904967A (en) * 1995-04-27 1999-05-18 Terumo Kabushiki Kaisha Puncture resistant medical material
US5931865A (en) 1997-11-24 1999-08-03 Gore Enterprise Holdings, Inc. Multiple-layered leak resistant tube
US6019788A (en) * 1996-11-08 2000-02-01 Gore Enterprise Holdings, Inc. Vascular shunt graft and junction for same
US6102884A (en) 1997-02-07 2000-08-15 Squitieri; Rafael Squitieri hemodialysis and vascular access systems
US6156016A (en) 1998-01-06 2000-12-05 Maginot Vascular Systems Catheter systems and associated methods utilizing removable inner catheter or catheters
US6261255B1 (en) 1998-11-06 2001-07-17 Ronald Jay Mullis Apparatus for vascular access for chronic hemodialysis
US6338724B1 (en) * 1999-03-29 2002-01-15 Christos D. Dossa Arterio-venous interconnection
US20020049403A1 (en) 2000-10-03 2002-04-25 Audencio Alanis Method and apparatus for permanent vascular access for hemodialysis
US6398764B1 (en) * 1994-01-18 2002-06-04 Vasca. Inc. Subcutaneously implanted cannula and method for arterial access
US6402767B1 (en) 1997-05-22 2002-06-11 Kensey Nash Corporation Anastomosis connection system and method of use
US6428571B1 (en) 1996-01-22 2002-08-06 Scimed Life Systems, Inc. Self-sealing PTFE vascular graft and manufacturing methods
US20040215337A1 (en) 2003-04-24 2004-10-28 Scimed Life Systems, Inc. AV grafts with rapid post-operative self-sealing capabilities
US20050137614A1 (en) 2003-10-08 2005-06-23 Porter Christopher H. System and method for connecting implanted conduits
US20050203457A1 (en) 2004-03-15 2005-09-15 Smego Douglas R. Apparatus and method for creating an arterio-venous connection in hemodialysis maintenance
US20050215938A1 (en) 2004-03-29 2005-09-29 Iftikhar Khan Hybrid arteriovenous shunt
US20060064159A1 (en) 2003-10-08 2006-03-23 Porter Christopher H Device and method for vascular access
US20070167901A1 (en) 2005-11-17 2007-07-19 Herrig Judson A Self-sealing residual compressive stress graft for dialysis

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US215938A (en) * 1879-05-27 Improvement in filters
US203457A (en) * 1878-05-07 Improvement in fruit-pickers
US167901A (en) * 1875-09-21 Improvement in registers
US64159A (en) * 1867-04-23 Henry smith
US3363926A (en) 1965-05-14 1968-01-16 Nat Lock Co Locking mechanism for a door lock assembly
US3490438A (en) * 1967-06-08 1970-01-20 Atomic Energy Commission Perfusion chamber and cannulae therefor
US3826257A (en) * 1972-07-14 1974-07-30 T Buselmeier Prosthetic shunt
US3814137A (en) 1973-01-26 1974-06-04 Baxter Laboratories Inc Injection site for flow conduits containing biological fluids
US3998222A (en) * 1974-04-15 1976-12-21 Shihata Alfred A Subcutaneous arterio-venous shunt with valve
US4076023A (en) 1975-08-01 1978-02-28 Erika, Inc. Resealable device for repeated access to conduit lumens
US4184489A (en) 1976-10-06 1980-01-22 Cordis Dow Corp. Infusion tube access site
US4133312A (en) 1976-10-13 1979-01-09 Cordis Dow Corp. Connector for attachment of blood tubing to external arteriovenous shunts and fistulas
JPS5714358Y2 (en) 1976-11-12 1982-03-24
US4214586A (en) 1978-11-30 1980-07-29 Ethicon, Inc. Anastomotic coupling device
US4496350A (en) 1980-04-08 1985-01-29 Renal Systems, Inc. Blood access device
DE3019996A1 (en) 1980-05-24 1981-12-03 Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen HOHLORGAN
US4427219A (en) 1981-01-26 1984-01-24 Robroy Industries Compression coupling
US4503568A (en) 1981-11-25 1985-03-12 New England Deaconess Hospital Small diameter vascular bypass and method
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US4550447A (en) 1983-08-03 1985-11-05 Shiley Incorporated Vascular graft prosthesis
GB8407706D0 (en) 1984-03-24 1984-05-02 Edgealpha Ltd Lining pipelines in passageways
US4917087A (en) 1984-04-10 1990-04-17 Walsh Manufacturing (Mississuaga) Limited Anastomosis devices, kits and method
US4772268A (en) 1984-05-25 1988-09-20 Cook Incorporated Two lumen hemodialysis catheter
JPH06105798B2 (en) 1985-12-13 1994-12-21 株式会社日立製作所 Optical communication semiconductor device
JPH0316599Y2 (en) 1986-01-06 1991-04-09
US4790826A (en) 1986-03-28 1988-12-13 Elftman Nancy W Percutaneous access port
US4753236A (en) 1986-04-08 1988-06-28 Healey Maureen A Temporary anastomotic device
SE453258B (en) 1986-04-21 1988-01-25 Medinvent Sa ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING
US4734094A (en) 1986-06-09 1988-03-29 Jacob Erwin T Catheter and method for cholangiography
SE455834B (en) 1986-10-31 1988-08-15 Medinvent Sa DEVICE FOR TRANSLUMINAL IMPLANTATION OF A PRINCIPLE RODFORMALLY RADIALLY EXPANDABLE PROSTHESIS
US4771777A (en) 1987-01-06 1988-09-20 Advanced Cardiovascular Systems, Inc. Perfusion type balloon dilatation catheter, apparatus and method
US5061276A (en) 1987-04-28 1991-10-29 Baxter International Inc. Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
DE3778542D1 (en) 1987-07-28 1992-05-27 Menck Gmbh DEVICE FOR SEPARATING TUBULAR FOUNDATION PILES UNDER WATER.
US5026513A (en) 1987-10-19 1991-06-25 W. L. Gore & Associates, Inc. Process for making rapidly recoverable PTFE
JP2801596B2 (en) 1987-11-05 1998-09-21 日本特殊陶業株式会社 Air-fuel ratio control method
US4919127A (en) 1988-05-03 1990-04-24 Pell Donald M Endotracheal tube connector
US5104402A (en) 1988-05-25 1992-04-14 Trustees Of The University Of Pennsylvania Prosthetic vessels for stress at vascular graft anastomoses
US5053023A (en) 1988-10-25 1991-10-01 Vas-Cath Incorporated Catheter for prolonged access
US5192289A (en) 1989-03-09 1993-03-09 Avatar Design And Development, Inc. Anastomosis stent and stent selection system
US5405320A (en) * 1990-01-08 1995-04-11 The Curators Of The University Of Missouri Multiple lumen catheter for hemodialysis
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
JPH0717314Y2 (en) 1990-10-18 1995-04-26 ソン ホーヨン Self-expanding intravascular stent
ES2112904T3 (en) 1991-04-05 1998-04-16 Boston Scient Corp A CATHETER SET FOR INSERTION WITHIN A BLOOD VESSEL.
US5171227A (en) 1991-04-16 1992-12-15 The Curators Of The University Of Missouri Separable peritoneal dialysis catheter
US5171305A (en) 1991-10-17 1992-12-15 Imagyn Medical, Inc. Linear eversion catheter with reinforced inner body extension
US5647855A (en) 1992-05-06 1997-07-15 Trooskin; Stanley Z. Self-healing diaphragm in a subcutaneous infusion port
US5735892A (en) 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5405339A (en) 1993-09-03 1995-04-11 Medtronic, Inc. Medical connector and method for connecting medical tubing
US5454790A (en) 1994-05-09 1995-10-03 Innerdyne, Inc. Method and apparatus for catheterization access
US5496294A (en) 1994-07-08 1996-03-05 Target Therapeutics, Inc. Catheter with kink-resistant distal tip
DE59408750D1 (en) 1994-07-12 1999-10-21 Eat Elektronische Ateliertechn Process for the realistic simulation of a real fabric consisting of warp and weft threads
US5669881A (en) 1995-01-10 1997-09-23 Baxter International Inc. Vascular introducer system incorporating inflatable occlusion balloon
US5674272A (en) 1995-06-05 1997-10-07 Ventritex, Inc. Crush resistant implantable lead
DE69635112T2 (en) 1995-07-07 2006-05-18 W.L. Gore & Associates, Inc., Newark INTERIOR COATING FOR TUBES AND BLOOD TUBES
US5631748A (en) 1995-11-16 1997-05-20 Xerox Corporation Color images having multiple separations with minimally overlapping halftone dots and reduced interpixel contrast
US5624413A (en) 1996-02-23 1997-04-29 Medical Components, Inc. Method for inserting a multiple catheter assembly
US5830184A (en) 1996-03-06 1998-11-03 Medical Components, Inc. Composite catheter stabilizing devices, methods of making the same and catheter extracting device
US5800514A (en) 1996-05-24 1998-09-01 Meadox Medicals, Inc. Shaped woven tubular soft-tissue prostheses and methods of manufacturing
US5669637A (en) 1996-05-29 1997-09-23 Optimize Technologies, Inc. Miniature fitting assembly for micro-tubing
US5755773A (en) 1996-06-04 1998-05-26 Medtronic, Inc. Endoluminal prosthetic bifurcation shunt
US6007544A (en) 1996-06-14 1999-12-28 Beth Israel Deaconess Medical Center Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US5931829A (en) * 1997-01-21 1999-08-03 Vasca, Inc. Methods and systems for establishing vascular access
US5957974A (en) 1997-01-23 1999-09-28 Schneider (Usa) Inc Stent graft with braided polymeric sleeve
US5997562A (en) 1997-06-13 1999-12-07 Percusurge, Inc. Medical wire introducer and balloon protective sheath
US6167765B1 (en) 1998-09-25 2001-01-02 The Regents Of The University Of Michigan System and method for determining the flow rate of blood in a vessel using doppler frequency signals
US7025741B2 (en) * 2003-06-06 2006-04-11 Creativasc Medical Llc Arteriovenous access valve system and process
US20060058867A1 (en) * 2004-09-15 2006-03-16 Thistle Robert C Elastomeric radiopaque adhesive composite and prosthesis

Patent Citations (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683926A (en) * 1970-07-09 1972-08-15 Dainippon Pharmaceutical Co Tube for connecting blood vessels
US3818511A (en) 1972-11-17 1974-06-25 Medical Prod Corp Medical prosthesis for ducts or conduits
US3882862A (en) 1974-01-11 1975-05-13 Olga Berend Arteriovenous shunt
US4318401A (en) * 1980-04-24 1982-03-09 President And Fellows Of Harvard College Percutaneous vascular access portal and catheter
JPS5714358A (en) 1980-07-02 1982-01-25 Toray Industries Antithrombus medical material
US4496349A (en) 1981-05-08 1985-01-29 Renal Systems, Inc. Percutaneous implant
JPS58168333A (en) 1982-03-29 1983-10-04 Fujitsu Ltd Phase comparing system of phase locking loop circuit
US4447237A (en) 1982-05-07 1984-05-08 Dow Corning Corporation Valving slit construction and cooperating assembly for penetrating the same
WO1984003036A1 (en) 1983-02-03 1984-08-16 Wallsten Hans Ivar Blood vessel prosthesis
US4619641A (en) 1984-11-13 1986-10-28 Mount Sinai School Of Medicine Of The City University Of New York Coaxial double lumen anteriovenous grafts
US4898669A (en) * 1987-06-16 1990-02-06 Claber S.P.A. Vascular access device, in particular for purification treatments of the blood
US4877661A (en) 1987-10-19 1989-10-31 W. L. Gore & Associates, Inc. Rapidly recoverable PTFE and process therefore
US4822341A (en) * 1987-11-20 1989-04-18 Impra, Inc. Vascular access fistula
US4929236A (en) * 1988-05-26 1990-05-29 Shiley Infusaid, Inc. Snap-lock fitting catheter for an implantable device
US5041098A (en) 1989-05-19 1991-08-20 Strato Medical Corporation Vascular access system for extracorporeal treatment of blood
JPH04507050A (en) 1989-05-19 1992-12-10 ストレイトー メディカル コーポレイション Vascular access system for extracorporeal processing of blood
US4955899A (en) 1989-05-26 1990-09-11 Impra, Inc. Longitudinally compliant vascular graft
US5476451A (en) * 1990-03-01 1995-12-19 Michigan Transtech Corporation Implantable access devices
US5399168A (en) * 1991-08-29 1995-03-21 C. R. Bard, Inc. Implantable plural fluid cavity port
JPH05212107A (en) 1991-09-07 1993-08-24 Hans Haindl Port catheter
US5197976A (en) * 1991-09-16 1993-03-30 Atrium Medical Corporation Manually separable multi-lumen vascular graft
US5192310A (en) * 1991-09-16 1993-03-09 Atrium Medical Corporation Self-sealing implantable vascular graft
US5866217A (en) 1991-11-04 1999-02-02 Possis Medical, Inc. Silicone composite vascular graft
US5840240A (en) 1991-11-04 1998-11-24 Possis Medical, Inc. Method of making a silicone composite vascular graft
JPH06105798A (en) 1992-09-30 1994-04-19 Terumo Corp Catheter tube
US5607463A (en) 1993-03-30 1997-03-04 Medtronic, Inc. Intravascular medical device
US6398764B1 (en) * 1994-01-18 2002-06-04 Vasca. Inc. Subcutaneously implanted cannula and method for arterial access
WO1995019200A1 (en) 1994-01-18 1995-07-20 Finch Charles David Jr Implantable vascular device
US5562618A (en) * 1994-01-21 1996-10-08 Sims Deltec, Inc. Portal assembly and catheter connector
US5558641A (en) * 1994-01-24 1996-09-24 Sims Deltec, Inc. Hybrid portal and method
DE4418910A1 (en) 1994-05-31 1995-12-07 Mouhamed Kamal Dr Med Koudaimi Dialysis port system and diaphragm
US5591226A (en) 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US5755775A (en) * 1995-01-23 1998-05-26 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
WO1996024399A1 (en) 1995-02-09 1996-08-15 The Curators Of The University Of Missouri Clot resistant multiple lumen catheter
US5904967A (en) * 1995-04-27 1999-05-18 Terumo Kabushiki Kaisha Puncture resistant medical material
US5676346A (en) * 1995-05-16 1997-10-14 Ivac Holdings, Inc. Needleless connector valve
US5637102A (en) * 1995-05-24 1997-06-10 C. R. Bard, Inc. Dual-type catheter connection system
US5743894A (en) * 1995-06-07 1998-04-28 Sherwood Medical Company Spike port with integrated two way valve access
US5637088A (en) * 1995-09-14 1997-06-10 Wenner; Donald E. System for preventing needle displacement in subcutaneous venous access ports
JPH0984871A (en) 1995-09-25 1997-03-31 Terumo Corp Medical tube and manufacture thereof
DE29515546U1 (en) 1995-09-29 1997-01-30 Schreiber Hans Vascular port, especially for hemodialysis
US20040193242A1 (en) 1996-01-22 2004-09-30 Scimed Life Systems, Inc. Self-sealing PTFE vascular graft and manufacturing methods
US6719783B2 (en) 1996-01-22 2004-04-13 Scimed Life Systems, Inc. PTFE vascular graft and method of manufacture
US6001125A (en) 1996-01-22 1999-12-14 Meadox Medicals, Inc. PTFE vascular prosthesis and method of manufacture
US5800512A (en) 1996-01-22 1998-09-01 Meadox Medicals, Inc. PTFE vascular graft
US6036724A (en) 1996-01-22 2000-03-14 Meadox Medicals, Inc. PTFE vascular graft and method of manufacture
US20030004559A1 (en) 1996-01-22 2003-01-02 Scimed Life Systems, Inc. PTFE vascular graft and method of manufacture
US6428571B1 (en) 1996-01-22 2002-08-06 Scimed Life Systems, Inc. Self-sealing PTFE vascular graft and manufacturing methods
US5830224A (en) * 1996-03-15 1998-11-03 Beth Israel Deaconess Medical Center Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo
US5797879A (en) * 1996-08-26 1998-08-25 Decampli; William M. Apparatus and methods for providing selectively adjustable blood flow through a vascular graft
US6019788A (en) * 1996-11-08 2000-02-01 Gore Enterprise Holdings, Inc. Vascular shunt graft and junction for same
US5792104A (en) * 1996-12-10 1998-08-11 Medtronic, Inc. Dual-reservoir vascular access port
US6582409B1 (en) * 1997-02-07 2003-06-24 Graftcath, Inc. Hemodialysis and vascular access systems
US20070123811A1 (en) 1997-02-07 2007-05-31 Squitieri Rafael P Squitieri hemodialysis and vascular access systems
US6102884A (en) 1997-02-07 2000-08-15 Squitieri; Rafael Squitieri hemodialysis and vascular access systems
US6402767B1 (en) 1997-05-22 2002-06-11 Kensey Nash Corporation Anastomosis connection system and method of use
US5931865A (en) 1997-11-24 1999-08-03 Gore Enterprise Holdings, Inc. Multiple-layered leak resistant tube
US6156016A (en) 1998-01-06 2000-12-05 Maginot Vascular Systems Catheter systems and associated methods utilizing removable inner catheter or catheters
US6261255B1 (en) 1998-11-06 2001-07-17 Ronald Jay Mullis Apparatus for vascular access for chronic hemodialysis
US6338724B1 (en) * 1999-03-29 2002-01-15 Christos D. Dossa Arterio-venous interconnection
US20020049403A1 (en) 2000-10-03 2002-04-25 Audencio Alanis Method and apparatus for permanent vascular access for hemodialysis
US20040215337A1 (en) 2003-04-24 2004-10-28 Scimed Life Systems, Inc. AV grafts with rapid post-operative self-sealing capabilities
US20050137614A1 (en) 2003-10-08 2005-06-23 Porter Christopher H. System and method for connecting implanted conduits
US20060064159A1 (en) 2003-10-08 2006-03-23 Porter Christopher H Device and method for vascular access
US20050203457A1 (en) 2004-03-15 2005-09-15 Smego Douglas R. Apparatus and method for creating an arterio-venous connection in hemodialysis maintenance
US20050215938A1 (en) 2004-03-29 2005-09-29 Iftikhar Khan Hybrid arteriovenous shunt
US20070167901A1 (en) 2005-11-17 2007-07-19 Herrig Judson A Self-sealing residual compressive stress graft for dialysis

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
A.S. Coulson, M.D., Ph.D, Judy Quarnstrom, I.V.N., J. Moshimia, M.D., "A Combination of the Elephant Trunk Anastomosis Techinique and Vascular Clips for Dialysis Grafts," Surgical Rounds, Nov. 1999, pp. 596 to 608.
Alan S. Coulson, M.D., Jagjit Singh, M.D., Joseph C. Moya, "Modification of Venous End of Dialysis Grafts: An Attempt to Reduce Neointimal Hyperplasia," Dialysis& Transplantation, vol. 29, No. 1, Jan. 2000, pp. 10 to 18.
International Search Report for PCT Application No. PCT/US98/01939 dated May 5, 1998 in 3 pages.
Interview Summary dated Mar. 11, 2009 for Co-Pending Appl. No. 11/417,658 in 4 pages.
Search Report for EP Application No. 05006233.0 dated Jun. 8, 2005 in 2 pages.
The Amendment dated Mar. 17, 2009 filed in Co-Pending Appl. No. 11/417,658 in 2 pages.
The Office Action dated Dec. 17, 2008 issued in Co-Pending Appl. No. 11/417,658 in 11 pages.

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44639E1 (en) 1997-02-07 2013-12-10 Hemosphere, Inc. Hemodialysis and vascular access system
US8690815B2 (en) 2003-10-08 2014-04-08 Hemosphere, Inc. Device and method for vascular access
USRE47154E1 (en) 2003-10-08 2018-12-11 Merit Medical Systems, Inc. Device and method for vascular access
US11446170B2 (en) 2004-09-08 2022-09-20 Limflow Gmbh Minimally invasive surgical apparatus and methods
US11241304B2 (en) 2006-04-20 2022-02-08 Limflow Gmbh Method for fluid flow through body passages
US8079973B2 (en) 2008-03-05 2011-12-20 Hemosphere Inc. Vascular access system
US10792413B2 (en) 2008-03-05 2020-10-06 Merit Medical Systems, Inc. Implantable and removable customizable body conduit
US10004842B2 (en) 2011-08-11 2018-06-26 Medical Components, Inc. Method and apparatus for the dialysis of blood
US10765795B2 (en) 2011-08-11 2020-09-08 Medical Components, Inc. Method and apparatus for the dialysis of blood
US10765794B2 (en) 2011-08-11 2020-09-08 Medical Components, Inc. Method and apparatus for the dialysis of blood
US11696981B2 (en) 2011-08-11 2023-07-11 Medical Components, Inc. Method and apparatus for the dialysis of blood
US10632296B2 (en) 2011-09-06 2020-04-28 Merit Medical Systems, Inc. Vascular access system with connector
US10213590B2 (en) 2011-09-06 2019-02-26 Merit Medical Systems, Inc. Vascular access system with connector
US11185676B2 (en) 2011-09-06 2021-11-30 Merit Medical Systems, Inc. Vascular access system with connector
US9278172B2 (en) 2011-09-06 2016-03-08 Cryolife, Inc. Vascular access system with connector
US11471262B2 (en) 2013-03-08 2022-10-18 Limflow Gmbh Methods for targeting a body passage to effect fluid flow
US10682453B2 (en) 2013-12-20 2020-06-16 Merit Medical Systems, Inc. Vascular access system with reinforcement member
US11413043B2 (en) 2016-11-10 2022-08-16 Merit Medical Systems, Inc. Anchor device for vascular anastomosis
US11383072B2 (en) 2017-01-12 2022-07-12 Merit Medical Systems, Inc. Methods and systems for selection and use of connectors between conduits
US11590010B2 (en) 2017-01-25 2023-02-28 Merit Medical Systems, Inc. Methods and systems for facilitating laminar flow between conduits
US11026704B2 (en) 2017-03-06 2021-06-08 Merit Medical Systems, Inc. Vascular access assembly declotting systems and methods
US11622846B2 (en) 2017-03-24 2023-04-11 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
US10925710B2 (en) 2017-03-24 2021-02-23 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
US11826504B2 (en) 2017-04-10 2023-11-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US11179543B2 (en) 2017-07-14 2021-11-23 Merit Medical Systems, Inc. Releasable conduit connectors
US11911585B2 (en) 2017-07-20 2024-02-27 Merit Medical Systems, Inc. Methods and systems for coupling conduits
US11331458B2 (en) 2017-10-31 2022-05-17 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
USD905853S1 (en) 2018-02-27 2020-12-22 Medical Components, Inc. Catheter tip
US11129965B2 (en) 2018-10-09 2021-09-28 Limflow Gmbh Devices and methods for catheter alignment
US11478614B2 (en) 2018-10-09 2022-10-25 Limflow Gmbh Method for accessing pedal veins for deep vein arterialization
US11116943B2 (en) 2018-10-09 2021-09-14 Limflow Gmbh Methods for accessing pedal veins
US11850379B2 (en) 2018-10-09 2023-12-26 Limflow Gmbh Devices and methods for catheter alignment
US11311700B2 (en) 2018-10-09 2022-04-26 Limflow Gmbh Methods for accessing pedal veins
US11612397B2 (en) 2019-11-01 2023-03-28 Limflow Gmbh Devices and methods for increasing blood perfusion to a distal extremity
USD984880S1 (en) 2020-11-06 2023-05-02 Medical Components, Inc. Clamp with indicator

Also Published As

Publication number Publication date
EP0973577A1 (en) 2000-01-26
US20070123811A1 (en) 2007-05-31
JP3995057B2 (en) 2007-10-24
DE69829468D1 (en) 2005-04-28
US6102884A (en) 2000-08-15
EP1550479B1 (en) 2015-09-16
DE69829468T2 (en) 2006-02-09
EP0973577B1 (en) 2005-03-23
AU6053498A (en) 1998-08-26
EP1550479A3 (en) 2005-08-03
US6582409B1 (en) 2003-06-24
EP1550479A2 (en) 2005-07-06
WO1998034676A1 (en) 1998-08-13
USRE44639E1 (en) 2013-12-10
JP2002515798A (en) 2002-05-28

Similar Documents

Publication Publication Date Title
USRE41448E1 (en) Squitieri hemodialysis and vascular access systems
US6053901A (en) Subcutaneously implanted cannula and method for arterial access
US6261255B1 (en) Apparatus for vascular access for chronic hemodialysis
US5755780A (en) Implantable vascular device
US6042569A (en) Subcutaneously implanted cannula and methods for vascular access
US5944688A (en) Implantable hemodialysis access port assembly
US6682498B2 (en) Methods and systems for subcutaneous graft implantation
US5931829A (en) Methods and systems for establishing vascular access
US6258079B1 (en) Method and systems for establishing vascular access
US7828781B2 (en) Implantable dialysis access port
US6761700B2 (en) Extra-corporeal vascular conduit
US20040133173A1 (en) Implantable dialysis access port
US8414530B2 (en) Vascular access device
US20050203457A1 (en) Apparatus and method for creating an arterio-venous connection in hemodialysis maintenance
WO1997012643A1 (en) Subcutaneously implanted cannula and method for arterial access
CA2278125A1 (en) Methods and systems for establishing vascular access
US11077239B2 (en) Tributary access device and methods of use

Legal Events

Date Code Title Description
AS Assignment

Owner name: GRAFTCATH, INC., WASHINGTON

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SQUITIERI, RAFAEL \\;REEL/FRAME:014181/0902

Effective date: 19991230

AS Assignment

Owner name: HEMOSPHERE, INC., MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:GRAFTCATH, INC.;REEL/FRAME:022562/0278

Effective date: 20080417

AS Assignment

Owner name: HEMOSPHERE MERGER CORP., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HEMOSPHERE, INC.;REEL/FRAME:024079/0130

Effective date: 20100309

AS Assignment

Owner name: HEMOSPHERE, INC., MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:HEMOSPHERE MERGER CORP.;REEL/FRAME:024640/0716

Effective date: 20100311

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 12

FEPP Fee payment procedure

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

CC Certificate of correction
AS Assignment

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA

Free format text: SECURITY AGREEMENT;ASSIGNOR:HEMOSPHERE, INC.;REEL/FRAME:028233/0305

Effective date: 20120517

AS Assignment

Owner name: CRYOLIFE, INC., GEORGIA

Free format text: MERGER;ASSIGNOR:HEMOSPHERE, INC.;REEL/FRAME:034723/0198

Effective date: 20141231

AS Assignment

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MARYLAND

Free format text: SECURITY INTEREST;ASSIGNOR:CRYOLIFE, INC.;REEL/FRAME:034947/0248

Effective date: 20150209

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA

Free format text: SECURITY INTEREST;ASSIGNOR:CRYOLIFE, INC.;REEL/FRAME:034947/0248

Effective date: 20150209

AS Assignment

Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT, MARYLAND

Free format text: ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT;REEL/FRAME:037146/0466

Effective date: 20151118

Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR

Free format text: ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT;REEL/FRAME:037146/0466

Effective date: 20151118

FEPP Fee payment procedure

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

AS Assignment

Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT, MARYLAND

Free format text: SECURITY INTEREST;ASSIGNORS:CRYOLIFE, INC., AS GRANTOR;VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR;ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR;REEL/FRAME:037569/0212

Effective date: 20160120

Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT, MAR

Free format text: SECURITY INTEREST;ASSIGNORS:CRYOLIFE, INC., AS GRANTOR;VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR;ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR;REEL/FRAME:037569/0212

Effective date: 20160120

AS Assignment

Owner name: MERIT MEDICAL SYSTEMS, INC., UTAH

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CRYOLIFE, INC.;REEL/FRAME:038961/0582

Effective date: 20160203

AS Assignment

Owner name: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT, NORTH CAROLINA

Free format text: SECURITY INTEREST;ASSIGNOR:MERIT MEDICAL SYSTEMS, INC.;REEL/FRAME:039609/0918

Effective date: 20160706

Owner name: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINIS

Free format text: SECURITY INTEREST;ASSIGNOR:MERIT MEDICAL SYSTEMS, INC.;REEL/FRAME:039609/0918

Effective date: 20160706

AS Assignment

Owner name: CRYOLIFE, INC., A FLORIDA CORPORATION, GEORGIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:039564/0191

Effective date: 20160203

AS Assignment

Owner name: CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.), GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.), GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: HEMOSPHERE, INC., GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.), G

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: CRYOLIFE ACQUISITION CORPORATION, GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: VALVE SPECIAL PURPOSE CO., LLC, GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.),

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: CRYOLIFE, INC., GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201